Processing 00000000.tx.1: Increased (CTG/CAG)n lengths in myotonic dystrophy type 1 and MachadoJoseph disease genes in idiopathic azoospermia patients Huichin Pan1, Yet-Young Li2, Tung-Cheng Li2, Wen-Tin Tsai1, Shuan-Yow Li1 and Kuang-Ming Hsiao1,3 1 Department of Life Sciences and 2 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, Republic of China  Abstract Top Abstract Introduction Materials and methods Results Discussion Acknowledgements References  BACKGROUND: An increase in CAG trinucleotide repeat length in the androgen receptor (AR) gene has been linked to idiopathic azoospermia. 

Phrase: "Increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(CTG/CAG)n lengths in myotonic dystrophy type 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1444754:Lengths [Quantitative Concept]
   708 E C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "MachadoJoseph disease genes in idiopathic azoospermia patients Huichin Pan1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0017337:Genes [Gene or Genome]
   720   C1416989:MAL gene [Gene or Genome]

Phrase: "Yet-Young Li2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450478:LI2 [Body Location or Region]
   827   C1422805:LI2 [Gene or Genome]

Phrase: "Tung-Cheng Li2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450478:LI2 [Body Location or Region]
   827   C1422805:LI2 [Gene or Genome]

Phrase: "Wen-Tin Tsai1,"

Phrase: "Shuan-Yow Li1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450477:LI1 [Body Location or Region]
   827   C1420713:LI1 [Gene or Genome]

Phrase: "and"

Phrase: "Kuang-Ming Hsiao1,"

Phrase: "3 1 Department of Life Sciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "and"

Phrase: "2 Institute of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C0021621:Institute of Medicine [Health Care Related Organization]
           institute medicine
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Chung Shan Medical University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205476:Medical [Functional Concept]

Phrase: "Taichung,"

Phrase: "Taiwan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "Republic of China  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Acknowledgements"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "BACKGROUND"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: ":"

Phrase: "An increase in CAG trinucleotide repeat length"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in the androgen receptor (AR) gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1367578:Androgen Receptor Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "been"

Phrase: "linked to idiopathic azoospermia."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004509:AZOSPERMIA [Disease or Syndrome]
   770   C0332240:Idiopathic [Functional Concept]
   770   C1321542:Azoospermia [Pathologic Function]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.2: METHODS: In order to test whether other (CAG/CTG)n loci are also affected, the (CAG/CTG)n frequency distribution at myotonic dystrophy type 1 (DM1), MachadoJoseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA) and spinocerebellar ataxia type 8 (SCA8) loci, in addition to the AR gene, was investigated in 48 azoospermia patients and 47 controls. 

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "other"

Phrase: "(CAG/CTG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179630:CTG [Medical Device]
   861   C1705968:CTG [Quantitative Concept]

Phrase: ")"

Phrase: "n loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "are"

Phrase: "also"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "the (CAG/CTG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179630:CTG [Medical Device]
   861   C1705968:CTG [Quantitative Concept]

Phrase: ")"

Phrase: "n frequency distribution at myotonic dystrophy type 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0237580:Frequency Distribution [Quantitative Concept]
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0520511:distribution [Idea or Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1704711:Distribution [Functional Concept]
   744   C1705502:Frequency [Quantitative Concept]

Phrase: "(DM1"

Phrase: ")"

Phrase: ","

Phrase: "MachadoJoseph disease (MJD),"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "dentatorubral-pallidoluysian atrophy (DRPLA)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "spinocerebellar ataxia type 8 (SCA8) loci,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1708726:Locus [Gene or Genome]
   722   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]

Phrase: "in addition to the AR gene,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1367578:Androgen Receptor Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "investigated in 48 azoospermia patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004509:AZOSPERMIA [Disease or Syndrome]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C1292732:investigated [Functional Concept]
   760   C1321542:Azoospermia [Pathologic Function]

Phrase: "and"

Phrase: "47 controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.3: RESULTS: The median CAG repeat length in the AR gene was significantly longer in azoospermia patients than in controls (23 versus 21, P < 0.001). 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: ":"

Phrase: "The median CAG repeat length in the AR gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1444754:Length [Quantitative Concept]
   739   C1706316:LENGTH [Research Activity]

Phrase: "was"

Phrase: "significantly longer in azoospermia patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]

Phrase: "than"

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "versus"

Phrase: "21,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.4: Significant differences were also noted in the upper tails of trinucleotide repeat length distributions at both DM1 and MJD loci between the two populations. 

Phrase: "Significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "noted in the upper tails of trinucleotide repeat length distributions"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   760   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0037775:Distributions [Spatial Concept]
   739   C0039259:Tails [Body Part, Organ, or Organ Component]
   739   C0205341:Repeat [Functional Concept]
   739   C1282910:Upper [Spatial Concept]
   739   C1444754:Length [Quantitative Concept]
   739   C1547730:Repeat [Temporal Concept]
   739   C1705914:Repeat [Conceptual Entity]
   739   C1706316:LENGTH [Research Activity]
   706 E C0520511:distribution [Idea or Concept]
   706   C1316572:Note [Clinical Attribute]
   706   C1317574:Note [Intellectual Product]
   706   C1369612:Note [Clinical Attribute]
   706 E C1704711:Distribution [Functional Concept]

Phrase: "at both DM1"

Phrase: "and"

Phrase: "MJD loci between the two populations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.5: At the DM1 locus, alleles of more than 18 repeats were observed only in azoospermia patients, and not in controls (P = 0.014). 

Phrase: "At the DM1 locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "alleles of more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002085:Alleles [Gene or Genome]

Phrase: "than 18 repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only in azoospermia patients,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004509:AZOSPERMIA [Disease or Syndrome]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205171:Only [Quantitative Concept]
   770   C1321542:Azoospermia [Pathologic Function]
   770   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "not in controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1518422:Not [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(P = 0.014"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450302:0.014" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.6: At the MJD locus, the frequency of normal alleles (ANs) with 29 or more CAG repeats was also much higher in azoospermia patients (29.2 versus 7.4%; P = 0.0001). 

Phrase: "At the MJD locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "the frequency of normal alleles"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C0017270:Allele Frequency [Quantitative Concept]
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "(ANs) with 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004388:ANS [Body System]

Phrase: "or"

Phrase: "more CAG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "was"

Phrase: "also much higher in azoospermia patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(29.2"

Phrase: "versus"

Phrase: "7.4%"

Phrase: "; P = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.7: However, the repeat length distribution at DRPLA and SCA8 loci did not differ in the two groups. 

Phrase: "However,"

Phrase: "the repeat length distribution at DRPLA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "SCA8 loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1708726:Locus [Gene or Genome]
   722   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ in the two groups."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205448:Two [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
Processing 00000000.tx.8: CONCLUSIONS: These data indicated that, at least in a subset of azoospermia patients, there was an increase in the number of trinucleotide repeats in some disease loci. 

Phrase: "CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: ":"

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of azoospermia patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "there"

Phrase: "was"

Phrase: "an increase in the number of trinucleotide repeats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in some disease loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.9: Thus, it is noteworthy to evaluate whether offspring of these azoospermia patients, if born by assisted reproductive technologies, have an increased risk of trinucleotide repeat diseases. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "noteworthy to"

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "whether"

Phrase: "offspring of these azoospermia patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Offspring [Family Group]

Phrase: "if"

Phrase: "born by assisted reproductive technologies,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0872104:Assisted Reproductive Technologies [Therapeutic or Preventive Procedure]
   806   C0035157:Reproductive Technologies [Therapeutic or Preventive Procedure]
   760   C0035150:Reproductive [Organism Function]
   760   C0039421:technologies [Occupation or Discipline]
   760   C0748342:REPRODUCTIVE [Classification]
   760   C1269765:Assisted [Finding]
   726   C0004897:Bear [Mammal]
   726 E C0018896:assist [Social Behavior]
   726 E C0557034:assist [Health Care Activity]

Phrase: "have"

Phrase: "an increased risk of trinucleotide repeat diseases."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1281905:diseases risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   728   C0277564:acquired diseases [Disease or Syndrome]
Processing 00000000.tx.10: Key words: DM1/genetic instability/idiopathic azoospermia/MJD/trinucleotide repeats  Introduction Top Abstract Introduction Materials and methods Results Discussion Acknowledgements References  Azoospermia is a common form of male infertility for which the underlying cause is largely unknown. 

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "DM1/genetic instability/idiopathic azoospermia/MJD/trinucleotide repeats  Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0440471:Genetic Materials [Gene or Genome]
   786   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Acknowledgements"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Azoospermia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004509:AZOSPERMIA [Disease or Syndrome]
  1000   C1321542:Azoospermia [Pathologic Function]

Phrase: "is"

Phrase: "a common form of male infertility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "for which"

Phrase: "the underlying cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015127:cause [Functional Concept]
   861   C1524003:Cause [Conceptual Entity]

Phrase: "is"

Phrase: "largely unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.11: Recent studies have suggested that many of the so-called idiopathic azoospermia may have a genetic basis. 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "many of the so-called idiopathic azoospermia"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0004509:AZOSPERMIA [Disease or Syndrome]
   748   C0332240:Idiopathic [Functional Concept]
   748   C0439064:Many [Quantitative Concept]
   748   C0747726:many [Conceptual Entity]
   748   C1321542:Azoospermia [Pathologic Function]
   714   C0679006:Call [Mental Process]
   714   C1947967:Call [Functional Concept]

Phrase: "may"

Phrase: "have"

Phrase: "a genetic basis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.12: For example, increased length of a polymorphic CAG repeat sequence in exon 1 of the androgen receptor (AR) gene was shown to be associated with idiopathic azoospermia (Dowsing et al., 1999; Yoshida et al., 1999; Mifsud et al., 2001) The CAG repeat in the AR gene encodes a polyglutamine tract in the transactivation domain of the protein. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "increased length of a polymorphic CAG repeat sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1444754:Length [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]

Phrase: "in exon 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the androgen receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "(AR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with idiopathic azoospermia"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0004509:AZOSPERMIA [Disease or Syndrome]
   770   C0332240:Idiopathic [Functional Concept]
   770   C1321542:Azoospermia [Pathologic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Dowsing et al.,"

Phrase: "1999"

Phrase: "; Yoshida et al.,"

Phrase: "1999"

Phrase: "; Mifsud et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "The CAG repeat in the AR gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205341:Repeat [Functional Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a polyglutamine tract in the transactivation domain of the protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1185740:Tract [Body Part, Organ, or Organ Component]
Processing 00000000.tx.13: The length of this repeat has been shown to be inversely correlated to the transactivation activity of AR (Chamberlain et al., 1994; Kazemi-Esfarjani et al., 1995). 

Phrase: "The length of this repeat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "inversely"

Phrase: "correlated to the transactivation activity of AR"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   793   C1148774:androgen receptor activity [Molecular Function]
   770   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C1152633:receptor activity [Molecular Function]
   767   C3158809:receptor transactivation [Physiologic Function]
   744   C0002844:Androgen [Hormone,Pharmacologic Substance]
   744   C0040624:Transactivation [Genetic Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1561536:*Activity [Idea or Concept]
   744   C1707520:Correlated [Qualitative Concept]
   744   C3536949:Androgen [Pharmacologic Substance]

Phrase: "(Chamberlain et al.,"

Phrase: "1994"

Phrase: "; Kazemi-Esfarjani et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.14: It appeared that shorter CAG repeat length was associated with an increased risk of prostate cancer (Giovannucci et al., 1997), as well as with the progression of breast cancer (Yu et al., 2000). 

Phrase: "It"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "that shorter CAG repeat length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C1444754:Length [Quantitative Concept]
   812   C1706316:LENGTH [Research Activity]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: "was"

Phrase: "associated with an increased risk of prostate cancer"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   793   C0376358:Cancer of Prostate [Neoplastic Process]
           Prostate Cancer
   793   C0600139:Cancer of Prostate [Neoplastic Process]
           Prostate Cancer
   793   C1954276:Prostate cancer risk [Finding]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C2984325:Prostate cancer [Functional Concept]
   770   C3541264:Prostate Cancer [Intellectual Product]
   767   C0596244:Cancer Risk [Quantitative Concept]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0033572:Prostate [Body Part, Organ, or Organ Component]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0998265:Cancer [Eukaryote]
   744   C1278980:Prostate [Body Part, Organ, or Organ Component]
   744   C1306459:Cancer [Finding]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Giovannucci et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "as well as with the progression of breast cancer"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   801   C0006142:Cancer of the Breast [Neoplastic Process]
           Cancer of Breast
           Breast Cancer
   801   C0678222:Cancer of the Breast [Neoplastic Process]
           Cancer of Breast
           Breast Cancer
   762   C0178874:cancer progression [Neoplastic Process]
   762   C1947901:Cancer Progression [Pathologic Function]
   742   C0006141:Breast [Body Part, Organ, or Organ Component]
   742   C0006826:Cancer [Neoplastic Process]
   742   C0205170:Well [Qualitative Concept]
   742   C0242656:progression [Pathologic Function]
   742   C0449258:Progression [Functional Concept]
   742   C0998265:Cancer [Eukaryote]
   742   C1268990:Breast [Body Part, Organ, or Organ Component]
   742   C1306459:Cancer [Finding]
   742   C3146287:Well [Manufactured Object]
   714 E C0153661:thoracic cancer [Neoplastic Process]

Phrase: "(Yu et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.15: In addition to male infertility, longer CAG repeat length was also shown to be linked with endometrial carcinoma (Sasaki et al., 2000), and might also increase the risk of BRCA1-associated breast cancer (Rebbeck et al., 1999) and male breast cancer (Young et al., 2000). 

Phrase: "In addition to male infertility,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021364:Male infertility [Disease or Syndrome]
   861   C0021359:Infertility [Disease or Syndrome]
   789 E C0232919:Infertile [Functional Concept]

Phrase: "longer CAG repeat length"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1444754:Length [Quantitative Concept]
   812   C1706316:LENGTH [Research Activity]
   741 E C1522425:Longest [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked with endometrial carcinoma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0476089:Endometrial Carcinoma [Neoplastic Process]
   770   C0007097:Carcinoma [Neoplastic Process]
   770   C0227843:Endometrial [Spatial Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(Sasaki et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "might"

Phrase: "also"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of BRCA1-associated breast cancer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0596244:Cancer Risk [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]

Phrase: "(Rebbeck et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "and"

Phrase: "male breast cancer"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C0238033:Male Breast Cancer [Neoplastic Process]
  1000   C0242787:male breast cancer [Neoplastic Process]
   901   C0006142:Breast Cancer [Neoplastic Process]
   901   C0222604:Male breast [Body Part, Organ, or Organ Component]
   901   C0678222:Breast Cancer [Neoplastic Process]
   859 E C0545560:male breasts [Body Location or Region]
   859 E C2327328:Male chest [Body Location or Region]
   851 E C0153661:thoracic cancer [Neoplastic Process]
   827   C0006141:Breast [Body Part, Organ, or Organ Component]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0024554:Male [Finding]
   827   C0086582:male [Population Group]
   827   C0998265:Cancer [Eukaryote]
   827   C1268990:Breast [Body Part, Organ, or Organ Component]
   827   C1306459:Cancer [Finding]
   827   C1706180:Male [Qualitative Concept]
   827   C1706428:Male [Qualitative Concept]
   827   C1706429:Male [Organism Attribute]
   771 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   771 E C1521735:Pectoral [Qualitative Concept]
   743 E C0817096:Chest [Body Location or Region]
   743 E C1527391:Chest [Body Location or Region]

Phrase: "(Young et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.16: Marked expansion of this CAG repeat (>40) in the AR gene is the genetic cause for spinal and bulbar muscular atrophy (SBMA, also known as Kennedy disease), with which androgen insensitivity and testicular atrophy are usually associated (Nagashima et al., 1988; La Spada et al., 1991). 

Phrase: "Marked expansion of this CAG repeat"

Phrase: "("

Phrase: ">40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "in the AR gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1367578:Androgen Receptor Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "the genetic cause for spinal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "bulbar muscular atrophy"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0026846:Muscular Atrophy [Disease or Syndrome]
   827   C0026845:Muscular [Tissue]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0442025:Muscular [Spatial Concept]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C1995013:Muscles [Body Part, Organ, or Organ Component]

Phrase: "(SBMA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705240:SBMA [Gene or Genome]
  1000   C1839259:SBMA [Disease or Syndrome]

Phrase: "also"

Phrase: "known as Kennedy disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1367578:Kennedy disease [Gene or Genome]
   833   C1839259:Kennedy's Disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205309:Known [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "with which androgen insensitivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2874204:Androgen insensitivity NOS [Disease or Syndrome]
   861   C0237677:Insensitivity [Finding]

Phrase: "and"

Phrase: "testicular atrophy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0156312:Testicular atrophy [Disease or Syndrome]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "are"

Phrase: "usually"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Nagashima et al.,"

Phrase: "1988"

Phrase: "; La Spada et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.17: Expansions of unstable trinucleotide repeats in a number of other gene loci also lead to many other non-reproductive hereditary disorders. 

Phrase: "Expansions of unstable trinucleotide repeats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0524894:Trinucleotide Repeat Expansions [Cell or Molecular Dysfunction]

Phrase: "in a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of other gene loci also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1708726:Gene Locus [Gene or Genome]
           Locus

Phrase: "lead to many"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "other non-reproductive hereditary disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0019247:hereditary disorders [Disease or Syndrome]
   812   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.18: Examples include CGG or CCG expansion in fragile X syndrome (FRAX), CTG expansion in myotonic dystrophy type 1 (DM1), CAG expansions in Huntington disease (HD), dentatorubral-pallidoluysian atrophy (DRPLA), spinocerebellar ataxias (SCAs, 1, 2, 6, 7) and MachadoJoseph disease (MJD). 

Phrase: "Examples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707959:Example [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "CGG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1864172:CGG [Disease or Syndrome]

Phrase: "or"

Phrase: "CCG expansion in fragile X syndrome"

Phrase: "(FRAX"

Phrase: ")"

Phrase: ","

Phrase: "CTG expansion in myotonic dystrophy type 1"

Phrase: "(DM1"

Phrase: ")"

Phrase: ","

Phrase: "CAG expansions in Huntington disease (HD),"

Phrase: "dentatorubral-pallidoluysian atrophy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "(DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "spinocerebellar ataxias"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0087012:Spinocerebellar Ataxias [Disease or Syndrome]
   861   C0004134:Ataxias [Sign or Symptom]
   777 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(SCAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0149575:SCA [Body Part, Organ, or Organ Component]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6,"

Phrase: "7"

Phrase: ")"

Phrase: "and"

Phrase: "MachadoJoseph disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.19: Although exactly how these repeat expansions cause disease is not clear, a hallmark of these diseases is `anticipation'; 

Phrase: "Although"

Phrase: "exactly how"

Phrase: "these repeat expansions"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "a hallmark of these diseases is `anticipation'"

Phrase: ";"
Processing 00000000.tx.20: i.e. the severity is greater and/or the age of onset becomes earlier in successive generations within the family (Timchenko and Caskey, 1996). 

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the severity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439793:Severity [Qualitative Concept]
  1000   C2983285:Severity [Intellectual Product]
   928 E C0205082:Severe [Qualitative Concept]

Phrase: "is"

Phrase: "greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "and/or"

Phrase: "the age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "becomes"

Phrase: "earlier in successive generations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1279919:Early [Temporal Concept]

Phrase: "within the family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "(Timchenko"

Phrase: "and"

Phrase: "Caskey,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.21: The clinical severity of these diseases is positively correlated with the length of the expanded trinucleotide repeats. 

Phrase: "The clinical severity of these diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0521117:disease severity [Qualitative Concept]
   753   C0439793:Severity [Qualitative Concept]
   753   C2983285:Severity [Intellectual Product]

Phrase: "is"

Phrase: "positively"

Phrase: "correlated with the length of the expanded trinucleotide repeats."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0524894:Trinucleotide Repeats, Expanded [Cell or Molecular Dysfunction]
   764   C0282537:Trinucleotide Repeats [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205229:expanded [Spatial Concept]
   742   C0205341:repeats [Functional Concept]
   742   C1444754:Length [Quantitative Concept]
   742   C1705914:Repeats [Conceptual Entity]
   742   C1706316:LENGTH [Research Activity]
   742   C1707520:Correlated [Qualitative Concept]
   708 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.22: Since the repeat length increases as it is transmitted, it is thought that the molecular basis of anticipation is meiotic instability of the trinucleotide repeat. 

Phrase: "Since"

Phrase: "the repeat length increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:increases [Functional Concept]

Phrase: "as"

Phrase: "it"

Phrase: "is"

Phrase: "transmitted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242781:Transmitted [Pathologic Function]
  1000   C0332289:transmitted [Functional Concept]
  1000   C1521797:Transmitted [Natural Phenomenon or Process]

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "that"

Phrase: "the molecular basis of anticipation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1853126:MOLECULAR BASIS [Idea or Concept]
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "meiotic instability of the trinucleotide repeat."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1444783:Instability [Finding]
Processing 00000000.tx.23: In addition to instability during gametogenesis, these trinucleotide repeats are also unstable in somatic cells, resulting in somatic heterogeneity (Timchenko and Caskey, 1996). 

Phrase: "In addition to instability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444783:Instability [Finding]

Phrase: "during gametogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017001:Gametogenesis [Organ or Tissue Function]
  1000   C1326810:gametogenesis [Organism Function]

Phrase: "these trinucleotide repeats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0282537:Trinucleotide Repeats [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "are"

Phrase: "also unstable in somatic cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0443343:Unstable [Finding]
   760   C1883468:UNSTABLE [Phenomenon or Process]

Phrase: "resulting in somatic heterogeneity"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0019409:Heterogeneity [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C2986476:Somatic [Qualitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "(Timchenko"

Phrase: "and"

Phrase: "Caskey,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.24: Recent advances in assisted reproductive technology, such as ICSI, have made it possible to treat most forms of azoospermia. 

Phrase: "Recent advances in assisted reproductive technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]

Phrase: "such as ICSI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0455164:ICSI [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "most forms of azoospermia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]
Processing 00000000.tx.25: However, the safety of ICSI remains of great concern because the overall genetic constitutions of azoospermia patients are not clear. 

Phrase: "However,"

Phrase: "the safety of ICSI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036043:Safety [Human-caused Phenomenon or Process]
   770   C1705187:SAFETY [Research Activity]

Phrase: "remains of great concern"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0549177:Great [Quantitative Concept]
   770   C1704243:Great [Quantitative Concept]
   770   C2699424:Concern [Idea or Concept]

Phrase: "because"

Phrase: "the overall genetic constitutions of azoospermia patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0009807:Constitutions [Regulation or Law]
   741   C0683521:patient constitution [Finding]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.26: Based on the facts that CAG repeat length in the AR gene may be enhanced in idiopathic azoospermia patients (Dowsing et al., 1999; Yoshida et al., 1999; Mifsud et al., 2001) and that testicular atrophy or reduced fertility is often associated with CTG repeat expansion in certain male DM1 patients (Harper, 1989; Hortas et al., 2000), it is important to know whether increases in trinucleotide repeat length might be found in other disease genes associated with expansion of trinucleotide repeats besides AR in idiopathic azoospermia patients. 

Phrase: "Based on the facts"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that CAG repeat length in the AR gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1444754:Length [Quantitative Concept]
   742   C1706316:LENGTH [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "enhanced in idiopathic azoospermia patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004509:AZOSPERMIA [Disease or Syndrome]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0332240:Idiopathic [Functional Concept]
   760   C1321542:Azoospermia [Pathologic Function]
   760   C2349975:Enhanced [Activity]

Phrase: "(Dowsing et al.,"

Phrase: "1999"

Phrase: "; Yoshida et al.,"

Phrase: "1999"

Phrase: "; Mifsud et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "that testicular atrophy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0156312:Testicular atrophy [Disease or Syndrome]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "or"

Phrase: "reduced fertility"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1867795:Reduced fertility [Finding]
   861   C0015895:Fertility [Organism Function]
   861   C0200069:Fertility [Diagnostic Procedure]
   861   C2986895:Fertility [Idea or Concept]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "associated with CTG repeat expansion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0179630:CTG [Medical Device]
   760   C0205341:Repeat [Functional Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C1705968:CTG [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in certain male DM1 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0150904:male patients [Organism Attribute]
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "(Harper,"

Phrase: "1989"

Phrase: "; Hortas et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "know"

Phrase: "whether"

Phrase: "increases in trinucleotide repeat length"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "found in other disease genes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   762   C1416989:MAL gene [Gene or Genome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0017337:Genes [Gene or Genome]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "associated with expansion of trinucleotide repeats"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   804   C0524894:Trinucleotide Repeat Expansion [Cell or Molecular Dysfunction]
   790   C0282537:Trinucleotide Repeats [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0205341:repeats [Functional Concept]
   753   C1705914:Repeats [Conceptual Entity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1547730:Repeat [Temporal Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "besides AR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "in idiopathic azoospermia patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.27: DM1 is caused by a CTG expansion in the 3'-untranslated region of the DM1 protein kinase (DM1PK) gene. 

Phrase: "DM1"

Phrase: "is"

Phrase: "caused by a CTG expansion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0179630:CTG [Medical Device]
   760   C1705968:CTG [Quantitative Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "in the 3'-untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600600:3' Untranslated Region [Biologically Active Substance,Nucleotide Sequence]
   913   C1883633:3' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the DM1 protein kinase (DM1PK) gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1414081:DM1 gene [Gene or Genome]
   875   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.28: MJD is the most popular form among the CAG trinucleotide repeat diseases, whereas DRPLA is relatively rare. 

Phrase: "MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "the most popular form among the CAG trinucleotide repeat diseases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "whereas"

Phrase: "DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "is"

Phrase: "relatively rare."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521114:Rare [Temporal Concept]
   861   C0522498:Rare [Qualitative Concept]
   861   C1514917:RARE [Gene or Genome]
Processing 00000000.tx.29: SCA8 is a newly defined disorder which contains CTG expansion in an untranslated region instead of CAG expansion found in the coding region of other SCAs (Koob et al., 1999). 

Phrase: "SCA8"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "is"

Phrase: "a newly defined disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "CTG expansion in an untranslated region"

Phrase: "instead of CAG expansion"

Phrase: "found in the coding region of other SCAs"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0079941:Coding Region [Gene or Genome]
   744   C0009219:Coding [Occupational Activity]
   744   C0017446:Region [Geographic Area]
   744   C0150312:Found [Quantitative Concept]
   744   C0205147:Region [Spatial Concept]
   711   C0149575:SCA [Body Part, Organ, or Organ Component]
   711 E C0243095:Find [Finding]
   711 E C0805701:Code [Intellectual Product]

Phrase: "(Koob et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.30: In this study, the (CTG/CAG)n distribution at the AR, DM1, MJD, DRPLA and SCA8 loci was investigated and compared in 48 idiopathic azoospermia patients and 47 normal male individuals, in order to test whether azoospermia patients contain longer trinucleotide repeat lengths in these disease loci.  

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the (CTG/CAG)n distribution at the AR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0520511:distribution [Idea or Concept]
   742   C1704711:Distribution [Functional Concept]

Phrase: "DM1,"

Phrase: "MJD,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "SCA8 loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1708726:Locus [Gene or Genome]
   722   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]

Phrase: "was"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "and"

Phrase: "compared in 48 idiopathic azoospermia patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0004509:AZOSPERMIA [Disease or Syndrome]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0332240:Idiopathic [Functional Concept]
   753   C1321542:Azoospermia [Pathologic Function]
   753   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "47 normal male individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "azoospermia patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "longer trinucleotide repeat lengths in these disease loci."
Processing 00000000.tx.31: Materials and methods Top Abstract Introduction Materials and methods Results Discussion Acknowledgements References  Study groups The 48 azoospermia patients were recruited from infertility clinics and were aged between 25 and 40 years. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Acknowledgements"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Study groups"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0441833:Group [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C2603343:Study [Research Activity]

Phrase: "The 48 azoospermia patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "recruited from infertility clinics"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C1552782:Infertility clinic [Intellectual Product]
   770   C0021359:Infertility [Disease or Syndrome]
   770   C0442592:clinics [Health Care Related Organization,Manufactured Object]
   737 E C0002424:Clinic [Health Care Related Organization,Manufactured Object]

Phrase: "and"

Phrase: "were"

Phrase: "aged between 25"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Aged [Organism Attribute]
   790   C0001792:Aged [Population Group]
   790   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "40 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.32: The patients were examined by either a urologist or a gynaecologist in the clinics, and were confirmed as having non-obstructive azoospermia. 

Phrase: "The patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "examined by either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332128:Examined [Finding]

Phrase: "a urologist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0260314:Urologist [Professional or Occupational Group]

Phrase: "or"

Phrase: "a gynaecologist in the clinics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0237419:Gynaecologist [Professional or Occupational Group]

Phrase: "and"

Phrase: "were"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "as"

Phrase: "having"

Phrase: "non-obstructive azoospermia."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1847540:Azoospermia, Nonobstructive [Disease or Syndrome]
   901   C0205304:Non-obstructive [Functional Concept]
   827   C0004509:AZOSPERMIA [Disease or Syndrome]
   827   C0549186:Obstructive [Functional Concept]
   827   C1321542:Azoospermia [Pathologic Function]
   827   C1518422:Non [Functional Concept]
Processing 00000000.tx.33: Patients who had varicocele and other obstructive syndromes of the seminal tract were excluded. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "had"

Phrase: "varicocele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042341:Varicocele [Disease or Syndrome]

Phrase: "and"

Phrase: "other obstructive syndromes of the seminal tract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0039082:Syndromes [Disease or Syndrome]
   748   C1558916:SYNDROMES [Finding]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.34: The 47 controls were unrelated Taiwanese males who were of similar age to the patients, apparently healthy, and proven fertile. 

Phrase: "The 47 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "unrelated Taiwanese males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0024554:Males [Finding]
   827   C0086582:Males [Population Group]
   793 E C1706180:Male [Qualitative Concept]
   793 E C1706428:Male [Qualitative Concept]
   793 E C1706429:Male [Organism Attribute]

Phrase: "who"

Phrase: "were of similar age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   770   C2348205:Similar [Qualitative Concept]

Phrase: "to the patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "apparently healthy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0018684:Health [Idea or Concept]
   789   C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "proven fertile."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0015895:Fertile [Organism Function]
   789 E C0200069:Fertility [Diagnostic Procedure]
   789 E C2986895:Fertility [Idea or Concept]
Processing 00000000.tx.35: All subjects provided their informed consent before blood samples were collected. 

Phrase: "All subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "their informed consent before blood samples"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0021430:Informed Consent [Regulation or Law]
   753   C1511481:Consent [Functional Concept]
   753   C1522154:Informed [Qualitative Concept]
   753   C1554192:consent [Idea or Concept]
   719 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C0700287:inform [Health Care Activity]
   719 E C1552002:inform [Idea or Concept]

Phrase: "were"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.36: A cytogenetic examination was carried out on each subject to confirm that all had normal male karyotypes. 

Phrase: "A cytogenetic examination"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on each"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "subject to"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "all"

Phrase: "had"

Phrase: "normal male karyotypes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   896   C0333684:Normal karyotype [Organism Attribute]
   896   C0863140:Normal karyotype [Finding]
   827   C0022526:karyotypes [Laboratory Procedure]
   827   C0178725:karyotypes [Laboratory or Test Result]
   827   C1261273:Karyotypes [Organism Attribute]
Processing 00000000.tx.37: Determination of trinucleotide repeat lengths Genomic DNA was extracted from the peripheral blood of each subject using a Puregene genomic DNA isolation kit (Gentra System, Minneapolis, MN, USA). 

Phrase: "Determination of trinucleotide repeat lengths Genomic DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "extracted from the peripheral blood of each subject"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   770   C0229664:peripheral blood [Body Substance]
           Blood
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C0205100:Peripheral [Spatial Concept]
   744   C0681850:Subject [Group]
   744   C1550501:{Subject} [Idea or Concept]
   744   C1706203:Subject [Idea or Concept]
   744   C2349001:Subject [Human]
   744   C2697811:Subject [Functional Concept]
   744   C3541890:EXTRACTED [Finding]
   729 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   711 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Puregene genomic DNA isolation kit (Gentra System,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   795   C0449913:System [Functional Concept]
   795   C1553451:System [Manufactured Object]
   795   C1704459:System [Medical Device]
   724 E C0205373:Systemic [Functional Concept]

Phrase: "Minneapolis,"

Phrase: "MN,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.38: The trinucleotide repeat length was determined by [35S]-dATP incorporated PCR followed by electrophoresis on denaturing polyacrylamide gel with 7 mol/l urea, as described previously (Hsiao et al., 1999). 

Phrase: "The trinucleotide repeat length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C1444754:Length [Quantitative Concept]
   827   C1706316:LENGTH [Research Activity]
   755 E C0205166:Long [Qualitative Concept]
   755 E C1522425:Longest [Qualitative Concept]
   755 E C1706317:Long [Qualitative Concept]
   734   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "determined by"

Phrase: "[35S"

Phrase: "]-dATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045186:dATP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "incorporated"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "followed by electrophoresis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "on denaturing polyacrylamide gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: "with 7 mol/l urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   756 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Hsiao et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.39: When a single band was obtained for a particular locus, it was proved to be homozygous by PCR-based Southern blot analysis (Hsiao et al., 1999). 

Phrase: "When"

Phrase: "a single band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "obtained for a particular locus,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1301820:Obtained [Functional Concept]
   760   C1708726:Locus [Gene or Genome]
   726 E C1706701:Obtain [Activity]

Phrase: "it"

Phrase: "was"

Phrase: "proved"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "homozygous by PCR-based Southern blot analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019904:Homozygous [Organism Attribute]

Phrase: "(Hsiao et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.40: Some of the fragments were also sequenced to verify accuracy in the trinucleotide repeat number calculation. 

Phrase: "Some of the fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205392:Some [Quantitative Concept]
   770   C0332255:fragments [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   770   C3540770:Some [Intellectual Product]
   737 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "accuracy in the trinucleotide repeat number calculation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443131:Accuracy [Qualitative Concept]
Processing 00000000.tx.41: All PCR reactions were denatured for 5 min at 95C, followed by 30 cycles of 1 min at 95C, 1 min at annealing temperature, 1 min at 72C, and completed by a final extension for 10 min at 72C. 

Phrase: "All PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "denatured for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "at 95C,"

Phrase: "followed by 30 cycles of 1 min"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332283:Followed by [Temporal Concept]
           followed
   774   C0456693:/30 min [Temporal Concept]
   774   C1301862:Min 1 [Temporal Concept]
   774   C1442458:30 min [Temporal Concept]
   757   C2348028:Cycle/min [Quantitative Concept]
   748   C0702093:/min [Temporal Concept]
   714   C1511572:Cycle [Temporal Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "at 95C,"

Phrase: "1 min at annealing temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1301862:Min 1 [Temporal Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: "1 min at 72C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "completed by a final extension"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205088:Final [Temporal Concept]
   760   C0205197:COMPLETED [Qualitative Concept]
   760   C0231448:Extension [Functional Concept]
   760   C1546485:Final [Idea or Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 72C."
Processing 00000000.tx.42: The annealing temperatures were 55, 62, 61, 58 and 54C for AR, DM1, MJD, DRPLA and SCA8 respectively. 

Phrase: "The annealing temperatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0039476:Temperatures [Quantitative Concept]
   827 E C0005903:temperature [Organism Attribute]

Phrase: "were"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "62,"

Phrase: "61,"

Phrase: "58"

Phrase: "and"

Phrase: "54C for AR,"

Phrase: "DM1,"

Phrase: "MJD,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "SCA8 respectively."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   888   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   840   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   804   C0004134:Ataxia [Sign or Symptom]
   804   C0332307:Type [Qualitative Concept]
   804   C1547052:*Type [Quantitative Concept]
   733 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.43: The reaction mixtures contained 10 ng genomic DNA, 400 mol of dNTP, 0.5 mol of each primer, 5 Ci of -[35S]-dATP, 1X PCR buffer (J buffer for AR, I buffer for DM1, SCA8 and MJD, and K buffer for DRPLA) and 0.25 U of DNA polymerase, using the FailSafeTM PCR system (Epicentre, Madison, WI, USA). 

Phrase: "The reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "10 ng genomic DNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017428:Genomic [Gene or Genome]
   812   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "400 mol of dNTP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0027960:Mole [Neoplastic Process]
   770   C0324740:Mole [Mammal]
   770   C0439189:Mole [Quantitative Concept]
   770   C1456781:mole [Neoplastic Process]
   770   C1824986:mol [Gene or Genome]

Phrase: "0.5 mol of each primer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0027960:Mole [Neoplastic Process]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1824986:mol [Gene or Genome]

Phrase: "5 Ci of -[35S"

Phrase: "]-dATP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045186:dATP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1X PCR buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(J buffer for AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "I buffer for DM1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "SCA8"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "MJD,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "K buffer for DRPLA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "0.25 U of DNA polymerase,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the FailSafeTM PCR system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Epicentre,"

Phrase: "Madison,"

Phrase: "WI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.44: The primer sequences were as described (Fu et al., 1991; Kawaguchi et al., 1994; Koide et al., 1994; Monckton et al., 1995; Koob et al., 1999): for AR, 5'ACCAGGTAGCCTGTGGGGCCTCTA CGATGGGC3'(sense) and 5'CCAGAGCGTGCGCGAAGTGATCCAGAACCCG3' (antisense); 

Phrase: "The primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Fu et al.,"

Phrase: "1991"

Phrase: "; Kawaguchi et al.,"

Phrase: "1994"

Phrase: "; Koide et al.,"

Phrase: "1994"

Phrase: "; Monckton et al.,"

Phrase: "1995"

Phrase: "; Koob et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ":"

Phrase: "for AR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "5'ACCAGGTAGCCTGTGGGGCCTCTA CGATGGGC3'"

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'CCAGAGCGTGCGCGAAGTGATCCAGAACCCG3'"

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.45: for DM1, 5'CAGTTCACAACCGCTCCGAG3' (sense) and 5'CTTCCCAGGCCTGCAGTTTGCCCATC3' (antisense); 

Phrase: "for DM1,"

Phrase: "5'CAGTTCACAACCGCTCCGAG3'"

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'CTTCCCAGGCCTGCAGTTTGCCCATC3'"

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.46: for MJD, 5'CCAGTGACTACTTTGATTCG3' (sense) and 5'ATCCATGTGCAAAGGCCAGCC3' (antisense); 

Phrase: "for MJD,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "5'CCAGTGACTACTTTGATTCG3'"

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'ATCCATGTGCAAAGGCCAGCC3'"

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.47: for DRPLA, 5'CACCAGTCTCAACACATCACCATC3' (sense) and 5'CCTCCAGTGGGTGGGGAAATGCTC3' (antisense); 

Phrase: "for DRPLA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "5'CACCAGTCTCAACACATCACCATC3'"

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'CCTCCAGTGGGTGGGGAAATGCTC3'"

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.48: for SCA8, 5'TTTGAGAAAGGCTTGTGAGGACTGAGAATG3' (sense) and 5'GGTCCTTCATGTTAGAAAACCTGGCT3' (antisense). 

Phrase: "for SCA8,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "5'TTTGAGAAAGGCTTGTGAGGACTGAGAATG3'"

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'GGTCCTTCATGTTAGAAAACCTGGCT3'"

Phrase: "(antisense"

Phrase: ")."
Processing 00000000.tx.49: Statistical analysis The median, mean and standard error of the mean trinucleotide repeat length for each locus were calculated. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "The median,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "standard error of the mean trinucleotide repeat length"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   869   C1710181:Standard Error of the Mean [Quantitative Concept]
           Standard Error
   744   C0743559:error [Qualitative Concept]
   744   C1442989:Standard [Qualitative Concept]
   744   C1608199:Error [Functional Concept]
   744   C2828392:Standard [Intellectual Product]

Phrase: "for each locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "were"

Phrase: "calculated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.50: Since the (CTG/CAG)n lengths did not follow the normal distribution, the difference between azoospermia and control groups was tested by the MannWhitney U-test, and the difference of the frequency of larger alleles in each locus between azoospermia and control groups was tested by 2 analysis. 

Phrase: "Since"

Phrase: "the (CTG/CAG)n lengths"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   812   C1444754:Lengths [Quantitative Concept]
   779 E C1706316:LENGTH [Research Activity]
   729 E C0205166:Long [Qualitative Concept]
   729 E C1522425:Longest [Qualitative Concept]
   729 E C1706317:Long [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "the normal distribution,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0028377:Normal Distribution [Quantitative Concept]
  1000   C0332617:Normal distribution [Qualitative Concept]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]
   861   C2347086:% Normal [Quantitative Concept]

Phrase: "the difference between azoospermia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "tested by the MannWhitney U-test,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0683443:test test [Diagnostic Procedure]
   753   C0392366:tested [Intellectual Product]
   719 E C0022885:Test [Laboratory Procedure]
   719 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "the difference of the frequency of larger alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "in each locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "between azoospermia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004509:AZOSPERMIA [Disease or Syndrome]
  1000   C1321542:Azoospermia [Pathologic Function]

Phrase: "and"

Phrase: "control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "tested by 2 analysis."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0392366:tested [Intellectual Product]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]
Processing 00000000.tx.51: A P-value < 0.05 was considered statistically significant.  

Phrase: "A P-value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "< 0.05"

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.52: Results Top Abstract Introduction Materials and methods Results Discussion Acknowledgements References  The median AR CAG repeat length was significantly higher in azoospermia patients than in fertile controls (23 versus 21; P < 0.001) (Table I). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Acknowledgements"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The median AR CAG repeat length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C1444754:Length [Quantitative Concept]
   799   C1706316:LENGTH [Research Activity]
   727 E C0205166:Long [Qualitative Concept]
   727 E C1522425:Longest [Qualitative Concept]
   727 E C1706317:Long [Qualitative Concept]

Phrase: "was"

Phrase: "significantly higher in azoospermia patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in fertile controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   947   C0700589:Fertility Control [Therapeutic or Preventive Procedure]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "versus"

Phrase: "21"

Phrase: "; P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.53: The distribution of CAG repeat lengths is shown in Figure 1A. 

Phrase: "The distribution of CAG repeat lengths"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "is"

Phrase: "shown in Figure 1A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450344:1A [Intellectual Product]
   770   C1553633:1a [Medical Device]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.54: The CAG repeat size ranged from 10 to 41 in azoospermia patients, and from 14 to 27 in controls. 

Phrase: "The CAG repeat size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456389:size [Spatial Concept]

Phrase: "ranged from 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 41"

Phrase: "in azoospermia patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and from 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 27"

Phrase: "in controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.55: Four of the azoospermia patients were found to have CAG repeat lengths >27, compared with none of the control men (Table II; P = 0.043). 

Phrase: "Four of the azoospermia patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004509:AZOSPERMIA [Disease or Syndrome]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0205450:Four [Quantitative Concept]
   760   C1321542:Azoospermia [Pathologic Function]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "CAG repeat lengths"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C1444754:Lengths [Quantitative Concept]
   793 E C1706316:LENGTH [Research Activity]
   743 E C0205166:Long [Qualitative Concept]
   743 E C1522425:Longest [Qualitative Concept]
   743 E C1706317:Long [Qualitative Concept]

Phrase: ">27,"

Phrase: "compared with none of the control men (Table II"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   762   C0025268:MEN II [Neoplastic Process]
   742   C0025266:Men [Population Group]
   742   C0039224:Table [Manufactured Object]
   742   C0243148:control [Qualitative Concept]
   742   C0456148:None [Quantitative Concept]
   742   C0549184:None [Quantitative Concept]
   742   C1550141:Control [Substance]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]
   742   C1707455:Compared [Activity]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708 E C0024554:MAN [Finding]
   708 E C0086418:Man [Human]

Phrase: "; P = 0.043"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.56: View this table: [in this window] [in a new window]  Table I. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.57: Trinucleotide repeat lengths in five disease genes in azoospermia and control groups  View larger version (23K): [in this window] [in a new window]  Figure 1. 

Phrase: "Trinucleotide repeat lengths in five disease genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0872146:disease length [Temporal Concept]
   748   C1444754:Lengths [Quantitative Concept]
   714 E C1706316:LENGTH [Research Activity]

Phrase: "in azoospermia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004509:AZOSPERMIA [Disease or Syndrome]
  1000   C1321542:Azoospermia [Pathologic Function]

Phrase: "and"

Phrase: "control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.58: Distribution of (CTG/CAG) repeat lengths in idiopathic azoospermia (closed bars) and control (open bars) groups at AR (A), DM1 (B), MJD (C), DRPLA (D) and SCA8 (E) loci.  

Phrase: "Distribution of (CTG/CAG)"

Phrase: "repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "lengths in idiopathic azoospermia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1444754:Lengths [Quantitative Concept]
   737 E C1706316:LENGTH [Research Activity]

Phrase: "(closed bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "groups at AR"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0002844:Androgen [Hormone,Pharmacologic Substance]
   770   C0441833:Group [Idea or Concept]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C3536949:Androgen [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "DM1"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(C), DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   861   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   812   C0333641:Atrophy [Pathologic Function]
   741 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "("

Phrase: "D)"

Phrase: "and"

Phrase: "SCA8"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(E) loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.59: View this table: [in this window] [in a new window]  Table II. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II."
Processing 00000000.tx.60: Comparison of longer trinucleotide repeats in five disease genes between azoospermia and control groups  To test whether other (CAG/CTG)n loci were affected in the genome of azoospermia patients, trinucleotide repeat numbers at four other disease loci, DM1, MJD, DRPLA and SCA8, were also determined in both patients and controls used in AR locus study. 

Phrase: "Comparison of longer trinucleotide repeats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "in five disease genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   856   C1416989:MAL gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "between azoospermia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004509:AZOSPERMIA [Disease or Syndrome]
  1000   C1321542:Azoospermia [Pathologic Function]

Phrase: "and"

Phrase: "control groups  To"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   901   C0009932:Control Groups [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "other"

Phrase: "(CAG/CTG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179630:CTG [Medical Device]
   861   C1705968:CTG [Quantitative Concept]

Phrase: ")"

Phrase: "n loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "were"

Phrase: "affected in the genome of azoospermia patients,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   774   C0522476:affected patients [Qualitative Concept]
   748   C0004509:AZOSPERMIA [Disease or Syndrome]
   748   C0017428:Genome [Gene or Genome]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0392760:Affected [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   748   C1321542:Azoospermia [Pathologic Function]
   748   C2338314:Genome [Conceptual Entity]
   714 E C0001721:Affect [Mental Process]

Phrase: "trinucleotide repeat numbers at four"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "other disease loci,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "DM1,"

Phrase: "MJD,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "SCA8,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "were"

Phrase: "also"

Phrase: "determined in both patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "used in AR locus study."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0869040:study use [Research Activity]
   753   C0002844:Androgen [Hormone,Pharmacologic Substance]
   753   C0557651:Study [Manufactured Object]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1273517:used [Finding]
   753   C1708726:Locus [Gene or Genome]
   753   C2603343:Study [Research Activity]
   753   C3536949:Androgen [Pharmacologic Substance]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.61: The mean, median and size range of trinucleotide repeat length at each locus in the two groups are listed in Table I. 

Phrase: "The mean,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "median"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "and"

Phrase: "size range of trinucleotide repeat length"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0456389:size [Spatial Concept]
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "at each locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "in the two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "are"

Phrase: "listed in Table I."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0021966:I- [Inorganic Chemical]
   770   C0039224:Table [Manufactured Object]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.62: None of these alleles showed pathological expansion (for normal repeat ranges versus disease ranges, see Table I). 

Phrase: "None of these alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002085:Alleles [Gene or Genome]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "pathological expansion"

Phrase: "("

Phrase: "for normal repeat ranges"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C0086715:Ranges, Normal [Quantitative Concept]
   827   C1514721:*Ranges [Quantitative Concept]
   793 E C2348147:Range [Quantitative Concept]
   793 E C3542016:Range [Intellectual Product]

Phrase: "versus"

Phrase: "disease ranges,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1514721:*Ranges [Quantitative Concept]
   827 E C2348147:Range [Quantitative Concept]
   827 E C3542016:Range [Intellectual Product]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.63: Figure 1BE shows the frequency distributions of trinucleotide repeat lengths for the four disease loci. 

Phrase: "Figure 1BE"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the frequency distributions of trinucleotide repeat lengths"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0037775:Distributions [Spatial Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]
   745   C0237580:Frequency Distribution [Quantitative Concept]
   714 E C0520511:distribution [Idea or Concept]
   714 E C1704711:Distribution [Functional Concept]

Phrase: "for the four disease loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.64: For the DM1 locus, the distribution was bimodal in both populations, with alleles of repeat numbers 5 and 12 as the most common. 

Phrase: "For the DM1 locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "the distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "bimodal in both populations,"

Phrase: "with alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "of repeat numbers 5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205341:Repeat [Functional Concept]
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "12 as the most common."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
Processing 00000000.tx.65: The size range of alleles was 5 to 17 in controls and 5 to 32 in azoospermia patients. 

Phrase: "The size range of alleles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0456389:size [Spatial Concept]
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "5 to 17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "5 to 32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]

Phrase: "in azoospermia patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.66: Notably, alleles with more than 18 CTG repeats were only detected in azoospermia patients (Figure 1B, Table II; P = 0.014). 

Phrase: "Notably,"

Phrase: "alleles with more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0002085:Alleles [Gene or Genome]

Phrase: "than 18 CTG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "detected in azoospermia patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004509:AZOSPERMIA [Disease or Syndrome]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0442726:Detected [Finding]
   770   C1321542:Azoospermia [Pathologic Function]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Figure 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "Table II"

Phrase: "; P = 0.014"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450302:0.014" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.67: The distribution of MJD alleles in the control group was also bimodal, with the highest peak at 16 repeat and the second peak at 28 repeat (Figure 1C). 

Phrase: "The distribution of MJD alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "also bimodal,"

Phrase: "with the highest peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "at 16 repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "the second peak at 28 repeat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0444505:Peak [Quantitative Concept]

Phrase: "(Figure 1C"

Phrase: ")."
Processing 00000000.tx.68: The distribution of MJD alleles in the azoospermia group was more diverse, with the second peak shifted to the right by two to three repeats (3031 repeats). 

Phrase: "The distribution of MJD alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in the azoospermia group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "more diverse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880371:Diverse [Qualitative Concept]

Phrase: "with the second peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "shifted to the right"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0427514:right shifted [Finding]
   770   C0205090:Right [Spatial Concept]
   770   C0333051:shifted [Functional Concept]
   737 E C2347509:Shift [Phenomenon or Process]

Phrase: "by two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "to three repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "(3031 repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.69: Statistical analysis showed that there was a significant over-representation of normal alleles (ANs) with 29 or more repeats in azoospermia patients (P = 0.0001; Table II). 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "was"

Phrase: "a significant over-representation of normal alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514861:Representation [Conceptual Entity]
   748   C1882932:Representation [Activity]

Phrase: "(ANs) with 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004388:ANS [Body System]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "repeats in azoospermia patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004509:AZOSPERMIA [Disease or Syndrome]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205341:Repeat [Functional Concept]
   770   C1321542:Azoospermia [Pathologic Function]
   770   C1547730:Repeat [Temporal Concept]
   770   C1705914:Repeat [Conceptual Entity]

Phrase: "(P = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Table II"

Phrase: ")."
Processing 00000000.tx.70: Frequency distributions of trinucleotide repeat lengths in the DRPLA and the recently defined SCA8 loci are shown in Figure 1D and E respectively. 

Phrase: "Frequency distributions of trinucleotide repeat lengths"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   756   C0237580:Frequency Distribution [Quantitative Concept]
   753   C0037775:Distributions [Spatial Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]
   719 E C0520511:distribution [Idea or Concept]
   719 E C1704711:Distribution [Functional Concept]

Phrase: "in the DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "the recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "SCA8 loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1708726:Locus [Gene or Genome]
   722   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]

Phrase: "are"

Phrase: "shown in Figure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "and"

Phrase: "E respectively."
Processing 00000000.tx.71: In the DRPLA locus, some (CAG)>20 alleles were observed that had not been reported previously in a normal Caucasian population; 

Phrase: "In the DRPLA locus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1708726:Locus [Gene or Genome]
   756   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]

Phrase: "some"

Phrase: "(CAG)>20 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously in a normal Caucasian population"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007457:Caucasian [Population Group]
   753   C0032659:Population [Quantitative Concept]
   753   C0043157:Caucasian [Population Group]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1257890:Population [Population Group]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.72: otherwise, the size ranges in the two groups were the same. 

Phrase: "otherwise,"

Phrase: "the size ranges in the two groups"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   774   C0237884:group size [Group Attribute]
   748   C0456389:size [Spatial Concept]
   748   C1514721:*Ranges [Quantitative Concept]
   714 E C2348147:Range [Quantitative Concept]
   714 E C3542016:Range [Intellectual Product]

Phrase: "were"

Phrase: "the same."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.73: In the SCA8 locus, the allele size ranged from 15 to 34 in control group, and from 18 to 39 in the azoospermia group (Table I). 

Phrase: "In the SCA8 locus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1708726:Locus [Gene or Genome]
   722   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]

Phrase: "the allele size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "ranged from 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 34"

Phrase: "in control group,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and from 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to 39"

Phrase: "in the azoospermia group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.74: Likewise, a previous report had shown that >99% of the ANs had 1637 repeats in this locus (Koob et al., 1999). 

Phrase: "Likewise,"

Phrase: "a previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "had"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: ">99% of the ANs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004388:ANS [Body System]

Phrase: "had"

Phrase: "1637 repeats in this locus"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205341:repeats [Functional Concept]
   760   C1705914:Repeats [Conceptual Entity]
   726 E C1547730:Repeat [Temporal Concept]

Phrase: "(Koob et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.75: In contrast to the DM1 and MJD loci, there were no differences in either the medians of trinucleotide repeat lengths or the frequencies of high-range alleles (>20 repeats for DRPLA or >30 repeats for SCA8) between the azoospermia and control groups in both the DRPLA and SCA8 genes (Tables I and II). 

Phrase: "In contrast to the DM1"

Phrase: "and"

Phrase: "MJD loci,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708726:Locus [Gene or Genome]

Phrase: "there"

Phrase: "were"

Phrase: "no differences in either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "the medians of trinucleotide repeat lengths"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0549183:medians [Spatial Concept]
   719 E C0876920:Median [Quantitative Concept]
   719 E C2347635:Median [Quantitative Concept]
   719 E C2348144:Median [Quantitative Concept]
   719 E C2939193:Median [Spatial Concept]

Phrase: "or"

Phrase: "the frequencies of high-range alleles"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   767   C0017270:Frequencies, Allele [Quantitative Concept]
   767   C0205212:High frequency [Temporal Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "("

Phrase: ">20 repeats for DRPLA or >30 repeats"

Phrase: "for SCA8"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: ")"

Phrase: "between the azoospermia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004509:AZOSPERMIA [Disease or Syndrome]
  1000   C1321542:Azoospermia [Pathologic Function]

Phrase: "and"

Phrase: "control groups in both"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0009932:Control Groups [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1550141:Control [Substance]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "the DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "and"

Phrase: "SCA8 genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   894   C1441233:Spinocerebellar ataxia gene [Gene or Genome]
   804   C0017337:Genes [Gene or Genome]
   722   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]

Phrase: "(Tables I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: ")."
Processing 00000000.tx.76: Subsequently, the trinucleotide repeat lengths for all five loci in each of the azoospermia patients were carefully examined in order to investigate whether a person with large ANs at one of these loci was likely to have large ANs at other loci. 

Phrase: "Subsequently,"

Phrase: "the trinucleotide repeat lengths for all five loci"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1444754:Lengths [Quantitative Concept]
   711 E C1706316:LENGTH [Research Activity]

Phrase: "in each"

Phrase: "of the azoospermia patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "carefully"

Phrase: "examined in order to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332128:Examined [Finding]
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "a person with large ANs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027361:Person [Population Group]
   760   C2347489:Person [Group]

Phrase: "at one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of these loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "was"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "large ANs at other loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004388:ANS [Body System]
Processing 00000000.tx.77: The repeat numbers in all five genes for 13 patients having large ANs in the AR (>27), DM1 (>18) or MJD (>29) loci are listed in Table III. 

Phrase: "The repeat numbers in all five genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "for 13 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "having"

Phrase: "large ANs in the AR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004388:ANS [Body System]

Phrase: "("

Phrase: ">27"

Phrase: ")"

Phrase: ","

Phrase: "DM1"

Phrase: "("

Phrase: ">18"

Phrase: ")"

Phrase: "or"

Phrase: "MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "("

Phrase: ">29"

Phrase: ")"

Phrase: "loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "are"

Phrase: "listed in Table III."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0039224:Table [Manufactured Object]
   770   C0439070:III [Intellectual Product]
   770   C1705160:III [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.78: Among these 13 patients, seven were found to have large ANs in the AR/DM1 (patient A21), AR/MJD (patients A41 and A25), or DM1/MJD (patients A32, A36, A38, A40) loci. 

Phrase: "Among these 13 patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "large ANs in the AR/DM1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0004388:ANS [Body System]

Phrase: "(patient A21"

Phrase: ")"

Phrase: ","

Phrase: "AR/MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(patients A41"

Phrase: "and"

Phrase: "A25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "DM1/MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(patients A32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0386212:A32 [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A36,"

Phrase: "A38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548689:A38 [Intellectual Product]

Phrase: "A40"

Phrase: ")"

Phrase: "loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.79: For patient A41, large ANs were also present in the SCA8 locus. 

Phrase: "For patient A41,"

Phrase: "large ANs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004388:ANS [Body System]

Phrase: "were"

Phrase: "also"

Phrase: "present in the SCA8 locus."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   770   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   744   C0004134:Ataxia [Sign or Symptom]
   744   C0150312:Present [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0449450:Present [Idea or Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.80: Patients A17 and A27 contained large ANs in DRPLA and SCA8 loci respectively, in addition to the MJD locus. 

Phrase: "Patients A17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1548682:A17 [Intellectual Product]

Phrase: "and"

Phrase: "A27"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "large ANs in DRPLA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0004388:ANS [Body System]

Phrase: "and"

Phrase: "SCA8 loci respectively,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1708726:Locus [Gene or Genome]
   700   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]

Phrase: "in addition to the MJD locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.81: View this table: [in this window] [in a new window]  Table III. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]
Processing 00000000.tx.82: Trinucleotide repeat numbers of 13 azoospermia patients in the five disease genes   Discussion Top Abstract Introduction Materials and methods Results Discussion Acknowledgements References  Consistent with previous reports (Dowsing et al., 1999; Yoshida et al., 1999; Mifsud et al., 2001), it has been observed in the present study that the CAG repeat length in the AR gene was markedly longer in idiopathic azoospermia patients (Table I). 

Phrase: "Trinucleotide repeat numbers of 13 azoospermia patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C2360800:Number of patients [Finding]
   757   C1830427:Patient number [Intellectual Product]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "in the five disease genes   Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Acknowledgements"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Consistent with previous reports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Dowsing et al.,"

Phrase: "1999"

Phrase: "; Yoshida et al.,"

Phrase: "1999"

Phrase: "; Mifsud et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "observed in the present study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1441672:Observed [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "the CAG repeat length in the AR gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1444754:Length [Quantitative Concept]
   742   C1706316:LENGTH [Research Activity]

Phrase: "was"

Phrase: "markedly longer in idiopathic azoospermia patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0205166:Long [Qualitative Concept]
   719   C1706317:Long [Qualitative Concept]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.83: In addition, frequency distributions of trinucleotide repeat lengths at the DM1 and MJD loci in idiopathic azoospermia patients also deviated from those in controls. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "frequency distributions of trinucleotide repeat lengths"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   756   C0237580:Frequency Distribution [Quantitative Concept]
   753   C0037775:Distributions [Spatial Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]
   719 E C0520511:distribution [Idea or Concept]
   719 E C1704711:Distribution [Functional Concept]

Phrase: "at the DM1"

Phrase: "and"

Phrase: "MJD loci in idiopathic azoospermia patients also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1708726:Locus [Gene or Genome]

Phrase: "deviated from those in controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0012727:Deviated [Spatial Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.84: The CTG repeat numbers at the DM1 locus in the 47 control males were between 5 and 17, and this was consistent with results from a previous study in which only seven out of 496 (1.4%) normal Taiwanese chromosomes of both sexes were found to be (CTG)>18 alleles (Pan et al., 2001). 

Phrase: "The CTG repeat numbers at the DM1 locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "in the 47 control males"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0024554:Males [Finding]
   827   C0086582:Males [Population Group]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1706180:Male [Qualitative Concept]
   793 E C1706428:Male [Qualitative Concept]
   793 E C1706429:Male [Organism Attribute]

Phrase: "were between 5"

Phrase: "and"

Phrase: "17,"

Phrase: "and"

Phrase: "this"

Phrase: "was"

Phrase: "consistent with results"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "from a previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "in which only seven"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0205453:Seven [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "out of 496"

Phrase: "(1.4%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "normal Taiwanese chromosomes of both sexes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0036869:Sex Chromosomes [Cell Component]
   753   C0008633:Chromosomes [Cell Component]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be ("

Phrase: "CTG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0179630:CTG [Medical Device]
  1000   C1705968:CTG [Quantitative Concept]

Phrase: ")"

Phrase: ">18 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "(Pan et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.85: Other studies have also reported that frequencies of (CTG)>18 alleles were <1% in Chinese populations (Tishkoff et al., 1998; Zhang et al., 2000). 

Phrase: "Other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that frequencies of (CTG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179630:CTG [Medical Device]
   827   C1705968:CTG [Quantitative Concept]

Phrase: ")"

Phrase: ">18 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "were"

Phrase: "<1% in Chinese populations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0008120:chinese [Language]
   770   C0032659:Population [Quantitative Concept]
   770   C0152035:Chinese [Population Group]
   770   C1257890:Population [Population Group]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "(Tishkoff et al.,"

Phrase: "1998"

Phrase: "; Zhang et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.86: As a significant contrast, six out of the 96 chromosomes (6.25%) in azoospermia patients contained 19 or more CTG repeats at the DM1 locus (6/96 versus 0/94, P = 0.014 or versus 7/496, P = 0.003). 

Phrase: "As a significant contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "six out of the 96 chromosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0008633:Chromosomes [Cell Component]
   753   C0205452:Six [Quantitative Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]

Phrase: "(6.25%"

Phrase: ")"

Phrase: "in azoospermia patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "19"

Phrase: "or"

Phrase: "more CTG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179630:CTG [Medical Device]
   861   C1705968:CTG [Quantitative Concept]

Phrase: "repeats at the DM1 locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205341:Repeat [Functional Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C1708726:Locus [Gene or Genome]

Phrase: "(6/96"

Phrase: "versus"

Phrase: "0/94,"

Phrase: "P = 0.014"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450302:0.014" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "or"

Phrase: "versus"

Phrase: "7/496,"

Phrase: "P = 0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.87: In addition to DM1, the repeat length distribution at the MJD locus also showed similar skewness. 

Phrase: "In addition to DM1,"

Phrase: "the repeat length distribution at the MJD locus also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0520511:distribution [Idea or Concept]
   739   C1704711:Distribution [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar skewness."
Processing 00000000.tx.88: Although the median CAG repeat of MJD alleles was the same in both azoospermia patients and controls, the difference in the frequencies of large ANs (CAG>28) between these two groups was highly significant (28/96 versus 7/94, P = 0.0001). 

Phrase: "Although"

Phrase: "the median CAG repeat of MJD alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205341:Repeat [Functional Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]

Phrase: "was"

Phrase: "the same in both azoospermia patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0445247:Same [Qualitative Concept]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "the difference in the frequencies of large ANs (CAG>28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: ")"

Phrase: "between these two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "highly significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1299395:Highly significant [Qualitative Concept]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(28/96"

Phrase: "versus"

Phrase: "7/94,"

Phrase: "P = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.89: These results demonstrated that, in addition to the AR locus, the frequencies of large normal trinucleotide repeats in DM1 and MJD loci were increased in azoospermia patients. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrated"

Phrase: "that,"

Phrase: "in addition to the AR locus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1708726:Locus [Gene or Genome]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "the frequencies of large normal trinucleotide repeats"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   748   C0439603:Frequencies [Temporal Concept]
   714 E C0376249:frequency [Quantitative Concept]
   714 E C0871396:Frequency [Quantitative Concept]
   714 E C1561548:Frequency [Qualitative Concept]
   714 E C1705502:Frequency [Quantitative Concept]

Phrase: "in DM1"

Phrase: "and"

Phrase: "MJD loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708726:Locus [Gene or Genome]

Phrase: "were"

Phrase: "increased in azoospermia patients."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004509:AZOSPERMIA [Disease or Syndrome]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1321542:Azoospermia [Pathologic Function]
Processing 00000000.tx.90: Although the AR gene is expressed in the genital region and its function is directly involved in reproduction, there is no evidence that the DM1PK and MJD (ataxin-3) genes are directly involved in reproductive function. 

Phrase: "Although"

Phrase: "the AR gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1367578:Androgen Receptor Gene [Gene or Genome]
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "expressed in the genital region"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0446509:Genital region [Body Location or Region]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0559522:Genital [Body System]
   760   C1546649:Genital [Intellectual Product]
   760   C1550642:Genital [Body Substance]
   704 E C0035150:Reproduction [Organism Function]

Phrase: "and"

Phrase: "its function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "involved in reproduction,"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
   790   C0035150:Reproduction [Organism Function]
   790   C1314939:Involved [Functional Concept]
   734 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   734 E C0314603:Genetic [Functional Concept]
   734 E C0559522:Genital [Body System]
   734 E C1546649:Genital [Intellectual Product]
   734 E C1550642:Genital [Body Substance]
   706 E C0005615:Birth [Organism Function]
   706 E C0079946:origin [Classification]
   706 E C0439659:Origin [Temporal Concept]
   706 E C1550512:origin [Intellectual Product]
   706 E C1550722:birth [Idea or Concept]
   706 E C3245487:birth [Intellectual Product]

Phrase: "there"

Phrase: "is"

Phrase: "no evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the DM1PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: ")"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "involved in reproductive function."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0232896:Reproductive function [Physiologic Function]
   770   C0031843:function [Physiologic Function]
   770   C0035150:Reproductive [Organism Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C0748342:REPRODUCTIVE [Classification]
   770   C1314939:Involved [Functional Concept]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.91: Both DM1PK and ataxin-3 are widely expressed, with DM1PK more abundant in skeletal and cardiac muscle lineage (Jansen et al., 1992; Waring and Korneluk, 1998), and ataxin-3 more in the brain (neurones and glial cells) (Paulson et al., 1997; Wang et al., 1997). 

Phrase: "Both DM1PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "are"

Phrase: "widely"

Phrase: "expressed"

Phrase: ","

Phrase: "with DM1PK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "more abundant in skeletal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "cardiac muscle lineage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1881379:Lineage [Conceptual Entity]
   734   C0027061:Muscle, Cardiac [Tissue]

Phrase: "(Jansen et al.,"

Phrase: "1992"

Phrase: "; Waring"

Phrase: "and"

Phrase: "Korneluk,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ataxin-3 more in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "(neurones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0027882:Neurone [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "glial cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: ")"

Phrase: "(Paulson et al.,"

Phrase: "1997"

Phrase: "; Wang et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.92: Further analysis of the association of repeat lengths among different loci showed that most azoospermia patients with large ANs in the AR, DM1 or MJD loci also had large ANs at certain other loci (Table III). 

Phrase: "Further analysis of the association of repeat lengths"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "among different loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "most azoospermia patients with large ANs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "in the AR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0002844:Androgen [Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536949:Androgen [Pharmacologic Substance]

Phrase: "DM1"

Phrase: "or"

Phrase: "MJD loci also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1708726:Locus [Gene or Genome]

Phrase: "had"

Phrase: "large ANs at certain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004388:ANS [Body System]

Phrase: "other loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "(Table III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.93: This increase in repeat length was not universal, however, since a patient with large ANs in one locus did not necessarily contain large ANs in all other loci. 

Phrase: "This increase in repeat length"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "not universal, however,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0173021:Universal [Biomedical or Dental Material,Carbohydrate]
   827   C0175671:Universal [Qualitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1552870:Universal [Idea or Concept]

Phrase: "since"

Phrase: "a patient with large ANs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:*^patient [Patient or Disabled Group]

Phrase: "in one locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "did"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "large ANs in all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004388:ANS [Body System]

Phrase: "other loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.94: These data do not argue for an underlying defect in a common mechanism maintaining genome integrity, such as DNA replication or mismatch repair, in azoospermia patients. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "argue for an underlying defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "in a common mechanism maintaining genome integrity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205266:integrity [Qualitative Concept]
   804   C0872403:integrity [Individual Behavior]
   804   C1947912:Integrity [Qualitative Concept]

Phrase: "such as DNA replication"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0598312:DNA Replication [Genetic Function]
           Replication
  1000   C2984261:DNA replication [Functional Concept]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883725:replication [Qualitative Concept]
   789 E C0205173:Replicate [Functional Concept]
   789 E C0205341:Replicate [Functional Concept]

Phrase: "or"

Phrase: "mismatch repair,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1155661:Mismatch Repair [Genetic Function]
  1000   C2984283:Mismatch repair [Functional Concept]
   861   C0043240:Repair, NOS [Organism Function]
   861   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "in azoospermia patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.95: However, the results of the present study suggested that the genetic defects in azoospermia patients might somehow contribute to the trinucleotide repeat instability at certain loci. 

Phrase: "However,"

Phrase: "the results of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the genetic defects in azoospermia patients"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   762   C0000768:Birth Defects [Congenital Abnormality]
   762   C0220810:birth defects [Functional Concept]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0243067:defects [Functional Concept]
   753   C0314603:Genetic [Functional Concept]
   745 E C1737329:Birth defect [Congenital Abnormality]
   719 E C1457869:Defect [Functional Concept]
   719 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "might"

Phrase: "somehow"

Phrase: "contribute to the trinucleotide repeat instability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205341:Repeat [Functional Concept]
   753   C1444783:Instability [Finding]
   753   C1547730:Repeat [Temporal Concept]
   753   C1705914:Repeat [Conceptual Entity]
   753   C1880177:Contribute [Activity]

Phrase: "at certain loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.96: It has been shown that the prevalence of DM1 in a population is positively correlated with the number of alleles in the upper tail of the frequency distribution (Tishkoff et al., 1998; Mor-Cohen et al., 1997a,b). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the prevalence of DM1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "in a population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "is"

Phrase: "positively"

Phrase: "correlated with the number of alleles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002085:Alleles [Gene or Genome]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "in the upper tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: "of the frequency distribution"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0237580:Frequency Distribution [Quantitative Concept]
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0520511:distribution [Idea or Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1704711:Distribution [Functional Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "(Tishkoff et al.,"

Phrase: "1998"

Phrase: "; Mor-Cohen et al.,"

Phrase: "1997a,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.97: Similarly, there is a close association between the prevalence of MJD and the frequency of large ANs in distinct ethnic populations (Takano et al., 1998). 

Phrase: "Similarly,"

Phrase: "there"

Phrase: "is"

Phrase: "a close association between the prevalence of MJD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1511978:Disease Association [Temporal Concept]
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the frequency of large ANs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "in distinct ethnic populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0015031:Ethnic population, NOS [Population Group]
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "(Takano et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.98: An increasing amount of data has supported the hypothesis that the large ANs may further expand and thus contribute to generation of the trinucleotide repeat diseases. 

Phrase: "An increasing amount of data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "has"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the large ANs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004388:ANS [Body System]

Phrase: "may"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "contribute to generation of the trinucleotide repeat diseases."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0012634:Diseases [Disease or Syndrome]
   744   C0079411:Generation [Temporal Concept]
   744   C0205341:Repeat [Functional Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]
   744   C1880177:Contribute [Activity]
   744   C3146294:Generation [Activity]
Processing 00000000.tx.99: Therefore, an increased frequency of large ANs in the DM1 and MJD loci in the idiopathic azoospermia population may result in a greater predisposition towards DM1 and MJD. 

Phrase: "Therefore,"

Phrase: "an increased frequency of large ANs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in the DM1"

Phrase: "and"

Phrase: "MJD loci in the idiopathic azoospermia population"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1708726:Locus [Gene or Genome]

Phrase: "may"

Phrase: "result in a greater predisposition"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0012655:Predisposition [Clinical Attribute]
   760   C0220898:Predisposition [Organism Attribute]
   760   C0443228:greater [Quantitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1704243:Greater [Quantitative Concept]
   760   C2825142:Result [Finding]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "towards DM1"

Phrase: "and"

Phrase: "MJD."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.100: Since these trinucleotide repeat diseases are dominantly inherited, and many of them also show anticipation phenomena, it is very important to monitor the transmission of any large alleles to see whether they indeed continue to expand into disease alleles. 

Phrase: "Since"

Phrase: "these trinucleotide repeat diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
   734   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "dominantly"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "many of them also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "anticipation phenomena,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomena [Phenomenon or Process]

Phrase: "it"

Phrase: "is"

Phrase: "very important to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442824:Very [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the transmission of any large alleles to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0040722:transmission [Idea or Concept]
   748   C0242781:Transmission [Pathologic Function]
   748   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "whether"

Phrase: "they indeed"

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "expand into disease alleles."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0002085:Alleles [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205229:Expand [Spatial Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.101: ICSI has become a powerful technology for men with various spermatogenic disorders to increase their prospects of parenthood. 

Phrase: "ICSI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0455164:ICSI [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "become"

Phrase: "a powerful technology for men"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0039421:Technology [Occupation or Discipline]

Phrase: "with various spermatogenic disorders to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012634:Disorders [Disease or Syndrome]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "their prospects of parenthood."
Processing 00000000.tx.102: However, the genetic constitution of these infertile patientsand thus the safety of this technologyis of great concern. 

Phrase: "However,"

Phrase: "the genetic constitution of these infertile patientsand thus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0009807:Constitution [Regulation or Law]

Phrase: "the safety of this technologyis of great concern."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0036043:Safety [Human-caused Phenomenon or Process]
   744   C1705187:SAFETY [Research Activity]
Processing 00000000.tx.103: The present data indicated that, at least in a subset of the idiopathic azoospermia patients, the trinucleotide repeat length was increased in some disease loci. 

Phrase: "The present data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of the idiopathic azoospermia patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "the trinucleotide repeat length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C1444754:Length [Quantitative Concept]
   827   C1706316:LENGTH [Research Activity]
   755 E C0205166:Long [Qualitative Concept]
   755 E C1522425:Longest [Qualitative Concept]
   755 E C1706317:Long [Qualitative Concept]
   734   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "increased in some disease loci."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   751   C0277564:Acquired disease [Disease or Syndrome]
   726   C1708726:Locus [Gene or Genome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.104: This implied that these idiopathic azoospermia patients might be carriers of larger trinucleotide repeat alleles, and that this may ultimately result in an increased prevalence of heritable diseases among their offspring. 

Phrase: "This"

Phrase: "implied"

Phrase: "that"

Phrase: "these idiopathic azoospermia patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "might"

Phrase: "be"

Phrase: "carriers of larger trinucleotide repeat alleles,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0007294:carriers [Finding]
   719 E C0560175:Carrier [Finding]
   719 E C1706209:Carrier [Medical Device]
   719 E C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "may"

Phrase: "ultimately"

Phrase: "result in an increased prevalence of heritable diseases"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0012634:Diseases [Disease or Syndrome]
   744   C0033105:Prevalence [Quantitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0220900:prevalence [Quantitative Concept]
   744   C0439660:Heritable [Functional Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "among their offspring."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]
Processing 00000000.tx.105: The application of ICSI in the treatment of azoospermia patients, therefore, should be undertaken only after thorough genetic evaluation and screening, as was suggested previously (Johnson, 1998; Kim et al., 1998). 

Phrase: "The application of ICSI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]

Phrase: "in the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of azoospermia patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "therefore,"

Phrase: "should"

Phrase: "be"

Phrase: "undertaken"

Phrase: "only after thorough genetic evaluation"
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   806   C0846617:genetic evaluation [Health Care Activity]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0205171:Only [Quantitative Concept]
   760   C0220825:Evaluation [Functional Concept]
   760   C0314603:Genetic [Functional Concept]
   760   C1261322:Evaluation [Health Care Activity]
   760   C1720467:Only [Intellectual Product]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "and"

Phrase: "screening,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]

Phrase: "as"

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "previously"

Phrase: "(Johnson,"

Phrase: "1998"

Phrase: "; Kim et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.106: In summary, the present results showed that the trinucleotide repeat lengths at the DM1, MJD and AR loci, but not at DRPLA or SCA8, were significantly larger in idiopathic azoospermia patients than in control subjects. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the trinucleotide repeat lengths at the DM1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1444754:Lengths [Quantitative Concept]
   714 E C1706316:LENGTH [Research Activity]

Phrase: "MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "AR loci,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1708726:Locus [Gene or Genome]
   734   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1447749:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "but"

Phrase: "not at DRPLA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   806   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   760   C0333641:Atrophy [Pathologic Function]
   760   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "SCA8,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "were"

Phrase: "significantly larger in idiopathic azoospermia patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0443228:larger [Quantitative Concept]
   753   C0549177:Larger [Quantitative Concept]
   753   C1704243:Larger [Quantitative Concept]

Phrase: "than"

Phrase: "in control subjects."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.107: Whether the pathological mechanism of idiopathic azoospermia is associated with the mechanism that contributes to trinucleotide repeat instability remains to be further elucidated.  

Phrase: "Whether"

Phrase: "the pathological mechanism of idiopathic azoospermia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "associated with the mechanism"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C1292727:Associated mechanism [Functional Concept]
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "contributes to trinucleotide repeat instability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205341:Repeat [Functional Concept]
   760   C1444783:Instability [Finding]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C1880177:Contribute [Activity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "elucidated."
Processing 00000000.tx.108: Acknowledgements Top Abstract Introduction Materials and methods Results Discussion Acknowledgements References  The authors thank Dr Shan-Li Tseng for providing the azoospermia samples and Dr C.-C. 

Phrase: "Acknowledgements Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Acknowledgements"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Shan-Li Tseng for providing"

Phrase: "the azoospermia samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "Dr"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]

Phrase: "C.-C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.109: Lin for reading the manuscript. 

Phrase: "Lin for reading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0861352:LIN [Neoplastic Process]

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.110: This work was supported in part by grants from National Science Council, Taiwan (NSC89-2320-B-040-018 and NSC89-2320-B-040068) and from Chung-Shan Medical University (CSMC87-OM-B-001).  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by grants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018173:Grants [Quantitative Concept]
   966 E C1548284:Grant [Idea or Concept]

Phrase: "from National Science Council,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551807:Council [Population Group]

Phrase: "Taiwan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "(NSC89-2320-B-040-018"

Phrase: "and"

Phrase: "NSC89-2320-B-040068"

Phrase: ")"

Phrase: "and from Chung-Shan Medical University"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0041740:University [Manufactured Object,Organization]
   753   C0205476:Medical [Functional Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "(CSMC87-OM-B-001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0028971:OM [Geographic Area]
   812   C1705272:OM [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.111: Notes  3 To whom correspondence should be addressed at: Department of Life Sciences, Chung Shan Medical University, No. 

Phrase: "Notes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "3 To whom correspondence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0282413:Correspondence [Intellectual Product]
   770   C0439086:<3 [Quantitative Concept]
   770   C2827736:3+ [Quantitative Concept]
   770   C2981702:3+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Life Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Chung Shan Medical University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205476:Medical [Functional Concept]

Phrase: "No."
Processing 00000000.tx.112: 110, Sec. 

Phrase: "110,"

Phrase: "Sec."
Processing 00000000.tx.113: 1, Chien-Kuo North Road, Taichung, Taiwan 402, Republic of China. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "Chien-Kuo North Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "Taichung,"

Phrase: "Taiwan 402,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039260:Taiwan [Geographic Area]

Phrase: "Republic of China."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039260:Republic of China [Geographic Area]
   827   C0008115:China [Geographic Area]
Processing 00000000.tx.114: E-mail: kmh{at}csmu.edu.tw  References Top Abstract Introduction Materials and methods Results Discussion Acknowledgements References  Chamberlain, N.L., Driver, E.D. and Miesfeld, R.L. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "kmh{at}csmu.edu.tw"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0039260:TW [Geographic Area]
   804   C0332293:TW [Therapeutic or Preventive Procedure]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Acknowledgements"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Chamberlain,"

Phrase: "N.L., Driver,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0684312:driver [Population Group]
   827   C1556026:Driver [Professional or Occupational Group]
   827   C1705366:Driver [Medical Device]

Phrase: "E.D."

Phrase: "and"

Phrase: "Miesfeld,"

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.115: (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. 

Phrase: "(1994"

Phrase: ")"

Phrase: "The length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "location of CAG trinucleotide repeats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "in the androgen receptor N-terminal domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0205088:Terminal [Temporal Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "transactivation function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0031843:function [Physiologic Function]
   861   C0040624:Transactivation [Genetic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.116: Nucleic Acids Res., 22, 31813186.[Abstract] Dowsing, A.T., Yong, E.L., Clark, M., McLachlan, R.I., de Kretser, D.M. and Trounson, A.O. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "22,"

Phrase: "31813186."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dowsing,"

Phrase: "A.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "Yong,"

Phrase: "E.L., Clark,"

Phrase: "M."

Phrase: ","

Phrase: "McLachlan,"

Phrase: "R.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "de Kretser,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Trounson,"

Phrase: "A.O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029408:a o [Disease or Syndrome]
Processing 00000000.tx.117: (1999) Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Linkage between male infertility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "trinucleotide repeat expansion in the androgen-receptor gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0524894:Trinucleotide Repeat Expansion [Cell or Molecular Dysfunction]
   770   C0282537:Trinucleotide Repeat [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205341:Repeat [Functional Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.118: Lancet, 354, 640643.[ISI][Medline] Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick, R.G. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "354,"

Phrase: "640643."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "Y.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kuhl,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pizzuti,"

Phrase: "A.,"

Phrase: "Pieretti,"

Phrase: "M."

Phrase: ","

Phrase: "Sutcliffe,"

Phrase: "J.S.,"

Phrase: "Richards,"

Phrase: "S."

Phrase: ","

Phrase: "Verkerk,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Holden,"

Phrase: "J.J.,"

Phrase: "Fenwick,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.119: Jr, Warren, S.T. et al. 

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Warren,"

Phrase: "S."

Phrase: "T. et al."
Processing 00000000.tx.120: (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Variation of the CGG repeat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "at the fragile X site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0677504:Fragile Site [Nucleotide Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "results in genetic instability"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1444783:Instability [Finding]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: ":"

Phrase: "resolution of the Sherman paradox."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C2699488:Resolution [Conceptual Entity]
Processing 00000000.tx.121: Cell, 67, 10471058.[ISI][Medline] Giovannucci, E., Stampfer, M.J., Krithivas, K., Brown, M., Dahl, D., Brufsky, A., Talcott, J., Hennekens, C.H. and Kantoff, P.W. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "67,"

Phrase: "10471058."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Giovannucci,"

Phrase: "E.,"

Phrase: "Stampfer,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Krithivas,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."

Phrase: ","

Phrase: "Dahl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206461:DAL [Carbohydrate,Pharmacologic Substance]

Phrase: "D."

Phrase: ","

Phrase: "Brufsky,"

Phrase: "A.,"

Phrase: "Talcott,"

Phrase: "J.,"

Phrase: "Hennekens,"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Kantoff,"

Phrase: "P.W."
Processing 00000000.tx.122: (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. 

Phrase: "(1997"

Phrase: ")"

Phrase: "The CAG repeat within the androgen receptor gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205341:Repeat [Functional Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "its relationship to prostate cancer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.123: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.124: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.125: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.126: USA, 94, 33203323.[Abstract/Free FullText] Harper, P.S. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "94,"

Phrase: "33203323."

Phrase: "[Abstract/Free FullText"

Phrase: "] Harper,"

Phrase: "P.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.127: (1989) The myotonic disorders. 

Phrase: "(1989"

Phrase: ")"

Phrase: "The myotonic disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0553604:Myotonic Disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.128: In Emery, A.E.A. and Rimoin, D.L. 

Phrase: "In Emery,"

Phrase: "A.E."

Phrase: "A."

Phrase: "and"

Phrase: "Rimoin,"

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.129: (eds), Principles and Practice of Medical Genetics, 2nd edn. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "Principles"

Phrase: "and"

Phrase: "Practice of Medical Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237607:practice [Mental Process]
   770   C3245512:practice [Intellectual Product]

Phrase: "2nd edn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419408:EDN [Gene or Genome]
Processing 00000000.tx.130: Churchill Livingstone, Edinburgh. 

Phrase: "Churchill Livingstone,"

Phrase: "Edinburgh."
Processing 00000000.tx.131: Hortas, M.L., Castilla, J.A., Gil, M.T., Molina, J., Garrido, M.L., Morell, M. and Redondo, M. 

Phrase: "Hortas,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Castilla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1216185:Castilla [Plant]

Phrase: "J."

Phrase: "A.,"

Phrase: "Gil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412493:GIL [Gene or Genome]

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Molina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1915092:Molina [Eukaryote]

Phrase: "J.,"

Phrase: "Garrido,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Morell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Redondo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.132: (2000) Decreased sperm function of patients with myotonic muscular dystrophy. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Decreased sperm function of patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031843:function [Physiologic Function]
   760   C0037868:Sperm [Cell]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "with myotonic muscular dystrophy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242007:Myotonic muscular dystrophy [Disease or Syndrome]
   913   C0027126:Myotonic Dystrophy [Disease or Syndrome]
   913   C0410226:Myotonic Dystrophy [Disease or Syndrome]
   901   C0026850:Muscular Dystrophy [Congenital Abnormality,Disease or Syndrome]
   827   C0026845:Muscular [Tissue]
   827   C0333606:Dystrophy [Pathologic Function]
   827   C0442025:Muscular [Spatial Concept]
   755 E C0333607:Dystrophic [Functional Concept]
   755 E C1995013:Muscles [Body Part, Organ, or Organ Component]
Processing 00000000.tx.133: Hum. 

Phrase: "Hum."
Processing 00000000.tx.134: Reprod., 15, 445448.[Abstract/Free FullText] Hsiao, K.M., Lin, H.M., Pan, H., Li, T.C., Chen, S.S., Jou, S.B., Chiu, Y.L., Wu, M.F., Lin, C.C. and Li, S.Y. 

Phrase: "Reprod.,"

Phrase: "15,"

Phrase: "445448."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hsiao,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "T.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Jou,"

Phrase: "S."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chiu,"

Phrase: "Y.L., Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: "Y."
Processing 00000000.tx.135: (1999) Application of FTA sample collection and DNA purification system on the determination of CTG trinucleotide repeat size by PCR-based Southern blotting. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Application of FTA sample collection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185125:Application [Health Care Activity]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]

Phrase: "and"

Phrase: "DNA purification system on the determination of CTG trinucleotide repeat size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0449913:System [Functional Concept]
   738   C1553451:System [Manufactured Object]
   738   C1704459:System [Medical Device]

Phrase: "by PCR-based Southern blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0005862:Blotting, Southern [Molecular Biology Research Technique]
   844 E C1148472:Blot, Southern [Laboratory or Test Result]
   812   C1710133:Southern [Spatial Concept]
Processing 00000000.tx.136: J. 

Phrase: "J."
Processing 00000000.tx.137: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.138: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.139: Anal., 13, 188193.[ISI][Medline] Jansen, G., Mahadevan, M., Amemiya, C., Wormskamp, N., Segers, B., Hendriks, W., O'Hoy, K., Baird, S., Sabourin, L., Lennon, G. et al. 

Phrase: "Anal.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]

Phrase: "13,"

Phrase: "188193."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jansen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mahadevan,"

Phrase: "M."

Phrase: ","

Phrase: "Amemiya,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wormskamp,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Segers,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hendriks,"

Phrase: "W.,"

Phrase: "O'Hoy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Baird,"

Phrase: "S."

Phrase: ","

Phrase: "Sabourin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lennon,"

Phrase: "G. et al."
Processing 00000000.tx.140: (1992) Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Characterization of the myotonic dystrophy region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "predicts"

Phrase: "multiple protein isoform-encoding mRNAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.141: Nature Genet., 1, 261266.[ISI][Medline] Johnson, M.D. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "261266."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson,"

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.142: (1998) Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genetic risks of intracytoplasmic sperm injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1517512:Genetic Risk [Quantitative Concept]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0035647:Risks [Qualitative Concept]
   753   C0314603:Genetic [Functional Concept]

Phrase: "in the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of male infertility"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021364:Male infertility [Disease or Syndrome]
   861   C0021359:Infertility [Disease or Syndrome]
   789 E C0232919:Infertile [Functional Concept]

Phrase: ":"

Phrase: "recommendations for genetic counseling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034866:recommendations [Idea or Concept]

Phrase: "and"

Phrase: "screening."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]
Processing 00000000.tx.143: Fertil. 

Phrase: "Fertil."
Processing 00000000.tx.144: Steril., 70, 397411.[ISI][Medline] Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I. et al. 

Phrase: "Steril.,"

Phrase: "70,"

Phrase: "397411."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kawaguchi,"

Phrase: "Y.,"

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Taniwaki,"

Phrase: "M."

Phrase: ","

Phrase: "Aizawa,"

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "M."

Phrase: ","

Phrase: "Katayama,"

Phrase: "S."

Phrase: ","

Phrase: "Kawakami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakamura,"

Phrase: "S."

Phrase: ","

Phrase: "Nishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Akiguchi,"

Phrase: "I. et al."
Processing 00000000.tx.145: (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. 

Phrase: "(1994"

Phrase: ")"

Phrase: "CAG expansions in a novel gene"

Phrase: "for Machado-Joseph disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024408:Machado-Joseph Disease [Disease or Syndrome]
           Joseph Disease
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "at chromosome 14q32.1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0008651:Chromosome 1 [Cell Component]
   901   C1520600:14q32.1 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
   827   C1520599:14q32 [Cell Component]
Processing 00000000.tx.146: Nature Genet., 8, 221227.[ISI][Medline] Kazemi-Esfarjani, P., Trifiro, M.A. and Pinsky, L. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "221227."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kazemi-Esfarjani,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trifiro,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Pinsky,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.147: (1995) Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenic relevance for the (CAG)n-expanded neuronpathies. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Evidence for a repressive function of the long polyglutamine tract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the human androgen receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1447749:androgen receptor, human [Amino Acid, Peptide, or Protein,Receptor]
           Androgen Receptor
   901   C0034786:Androgen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0002844:Androgen [Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C3536949:Androgen [Pharmacologic Substance]

Phrase: ":"

Phrase: "possible pathogenic relevance for the (CAG)n-expanded neuronpathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2347946:Relevance [Qualitative Concept]
Processing 00000000.tx.148: Hum. 

Phrase: "Hum."
Processing 00000000.tx.149: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.150: Genet., 4, 523527.[Abstract] Kim, E.D., Bischoff, F.Z., Lipshultz, L.I. and Lamb, D.J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "523527."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kim,"

Phrase: "E."

Phrase: "D."

Phrase: ","

Phrase: "Bischoff,"

Phrase: "F.Z.,"

Phrase: "Lipshultz,"

Phrase: "L.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.151: (1998) Genetic concerns for the subfertile male in the era of ICSI. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genetic concerns for the subfertile male"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2699424:Concerns [Idea or Concept]

Phrase: "in the era"

Phrase: "of ICSI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0455164:ICSI [Therapeutic or Preventive Procedure]
Processing 00000000.tx.152: Prenat. 

Phrase: "Prenat."
Processing 00000000.tx.153: Diagn., 18, 13491365.[ISI][Medline] Koide, R., Ikeuchi, T., Onodera, O., Tanaka, H., Igarashi, S., Endo, K., Takahashi, H., Kondo, R., Ishikawa, A., Hayashi, T. et al. 

Phrase: "Diagn.,"

Phrase: "18,"

Phrase: "13491365."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koide,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ikeuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Onodera,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Tanaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Igarashi,"

Phrase: "S."

Phrase: ","

Phrase: "Endo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014175:Endo [Disease or Syndrome]
  1000   C1427293:ENDO [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ishikawa,"

Phrase: "A.,"

Phrase: "Hayashi,"

Phrase: "T. et al."
Processing 00000000.tx.154: (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). 

Phrase: "(1994"

Phrase: ")"

Phrase: "Unstable expansion of CAG repeat"

Phrase: "in hereditary dentatorubral-pallidoluysian atrophy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   861   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   812   C0333641:Atrophy [Pathologic Function]
   741 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "(DRPLA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   901   C0393578:Pallidoluysian atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.155: Nature Genet., 6, 913.[ISI][Medline] Koob, M.D., Moseley, M.L., Schut, L.J., Benzow, K.A., Bird, T.D., Day, J.W. and Ranum, L.P. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "6,"

Phrase: "913."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koob,"

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Moseley,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schut,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Benzow,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "J.W."

Phrase: "and"

Phrase: "Ranum,"

Phrase: "L.P."
Processing 00000000.tx.156: (1999) An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). 

Phrase: "(1999"

Phrase: ")"

Phrase: "An untranslated CTG expansion"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a novel form of spinocerebellar ataxia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "(SCA8"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1837454:SPINOCEREBELLAR ATAXIA 8 [Disease or Syndrome]
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: ")."
Processing 00000000.tx.157: Nature Genet., 21, 379384.[ISI][Medline] La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. and Fischbeck, K.H. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "21,"

Phrase: "379384."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] La Spada,"

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wilson,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lubahn,"

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Harding,"

Phrase: "A.E."

Phrase: "and"

Phrase: "Fischbeck,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.158: (1991) Androgen gene mutations in X-linked spinal and bulbar muscular atrophy. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Androgen gene mutations in X-linked spinal"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0678928:X-linked gene [Gene or Genome]
   778   C0596611:gene mutations [Genetic Function]
   774   C0314613:Linked gene [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "bulbar muscular atrophy."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0026846:Muscular Atrophy [Disease or Syndrome]
   827   C0026845:Muscular [Tissue]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0442025:Muscular [Spatial Concept]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C1995013:Muscles [Body Part, Organ, or Organ Component]
Processing 00000000.tx.159: Nature, 352, 7779.[ISI][Medline] Mifsud, A., Sim, C.K., Boettger-Tong, H., Moreira, S., Lamb, D.J., Lipshultz, L.I. and Yong, E.L. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "352,"

Phrase: "7779."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mifsud,"

Phrase: "A.,"

Phrase: "Sim,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420068:SIM [Gene or Genome]

Phrase: "C.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Boettger-Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0183964:Tong [Medical Device]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Moreira,"

Phrase: "S."

Phrase: ","

Phrase: "Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lipshultz,"

Phrase: "L.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Yong,"

Phrase: "E.L."
Processing 00000000.tx.160: (2001) Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trinucleotide"

Phrase: "(CAG)"

Phrase: "repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "polymorphisms in the androgen receptor gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0678951:gene polymorphisms [Genetic Function]
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "molecular markers of risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005516:molecular markers [Clinical Attribute]
           Marker
   819   C1519104:Markers, Risk [Qualitative Concept]

Phrase: "for male infertility."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021364:Male infertility [Disease or Syndrome]
   861   C0021359:Infertility [Disease or Syndrome]
   789 E C0232919:Infertile [Functional Concept]
Processing 00000000.tx.161: Fertil. 

Phrase: "Fertil."
Processing 00000000.tx.162: Steril., 75, 275281.[ISI][Medline] Monckton, D.G., Wong, L.J., Ashizawa, T. and Caskey, C.T. 

Phrase: "Steril.,"

Phrase: "75,"

Phrase: "275281."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Monckton,"

Phrase: "D."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wong,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Ashizawa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Caskey,"

Phrase: "C.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.163: (1995) Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Somatic mosaicism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1866227:Somatic mosaicism [Finding]
   861   C0026578:Mosaicism [Organism Attribute]
   861   C0392053:Mosaicism [Cell or Molecular Dysfunction]
   861   C2987512:mosaicism [Organism]

Phrase: "germline expansions,"

Phrase: "germline reversions"

Phrase: "and"

Phrase: "intergenerational reductions in myotonic dystrophy males"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0301630:reductions [Natural Phenomenon or Process]
   753   C0441610:reductions [Therapeutic or Preventive Procedure]
   719 E C0392756:Reduction [Qualitative Concept]

Phrase: ":"

Phrase: "small pool PCR analyses."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0200931:PCR analysis [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]
Processing 00000000.tx.164: Hum. 

Phrase: "Hum."
Processing 00000000.tx.165: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.166: Genet., 4, 18.[Abstract] Mor-Cohen, R., Magal, N., Gadoth, N., Shohat, T. and Shohat, M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "18."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mor-Cohen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Magal,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Gadoth,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shohat,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Shohat,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.167: (1997a) Correlation between the incidence of myotonic dystrophy in different groups in Israel and the number of CTG trinucleotide repeats in the myotonic gene. 

Phrase: "(1997a"

Phrase: ")"

Phrase: "Correlation between the incidence of myotonic dystrophy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "in different groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "in Israel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: "and"

Phrase: "the number of CTG trinucleotide repeats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in the myotonic gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.168: Am. 

Phrase: "Am."
Processing 00000000.tx.169: J. 

Phrase: "J."
Processing 00000000.tx.170: Med. 

Phrase: "Med."
Processing 00000000.tx.171: Genet., 71, 156159.[ISI][Medline] Mor-Cohen, R., Magal, N., Gadoth, N., Achiron, A., Shohat, T. and Shohat, M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "156159."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mor-Cohen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Magal,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Gadoth,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Achiron,"

Phrase: "A.,"

Phrase: "Shohat,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Shohat,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.172: (1997b) The lower incidence of myotonic dystrophy in Ashkenazic Jews compared to North African Jews is associated with a significantly lower number of CTG trinucleotide repeats. 

Phrase: "(1997b"

Phrase: ")"

Phrase: "The lower incidence of myotonic dystrophy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]

Phrase: "in Ashkenazic Jews"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022389:Jews [Population Group]
   861   C0178443:jews [Population Group]

Phrase: "compared to North African Jews"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0022389:Jews [Population Group]
   760   C0027567:African [Population Group]
   760   C0178443:jews [Population Group]
   760   C1707455:Compared [Activity]
   760   C1709269:North [Spatial Concept]

Phrase: "is"

Phrase: "associated with a significantly lower number of CTG trinucleotide repeats."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   760   C0282537:Trinucleotide Repeats [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   739   C0179630:CTG [Medical Device]
   739   C0205341:repeats [Functional Concept]
   739   C0237753:*Number [Quantitative Concept]
   739   C0441994:Lower [Spatial Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C1548802:Lower [Body Location or Region]
   739   C1705914:Repeats [Conceptual Entity]
   739   C1705968:CTG [Quantitative Concept]
   739   C2003888:Lower [Activity]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1547730:Repeat [Temporal Concept]
   706 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.173: Isr. 

Phrase: "Isr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:ISR [Geographic Area]
Processing 00000000.tx.174: J. 

Phrase: "J."
Processing 00000000.tx.175: Med. 

Phrase: "Med."
Processing 00000000.tx.176: Sci., 33, 190193.[ISI][Medline] Nagashima, T., Seko, K., Hirose, K., Mannen, T., Yoshimura, S., Arima, R., Nagashima, K. and Morimatsu, Y. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "33,"

Phrase: "190193."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nagashima,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Seko,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hirose,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mannen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yoshimura,"

Phrase: "S."

Phrase: ","

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nagashima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Morimatsu,"

Phrase: "Y."
Processing 00000000.tx.177: (1988) Familial bulbospinal muscular atrophy associated with testicular atrophy and sensory neuropathy: autopsy case report of two brothers. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Familial bulbospinal muscular atrophy"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0393547:bulbospinal muscular atrophy [Disease or Syndrome]
   923   C1839259:Bulbospinal muscular atrophy [Disease or Syndrome]
   861   C0026846:Muscular Atrophy [Disease or Syndrome]
   812   C0026845:Muscular [Tissue]
   812   C0333641:Atrophy [Pathologic Function]
   812   C0442025:Muscular [Spatial Concept]
   741 E C0151514:Atrophic [Disease or Syndrome]
   741 E C1995013:Muscles [Body Part, Organ, or Organ Component]

Phrase: "associated with testicular atrophy"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0156312:Testicular atrophy [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205070:Testicular [Spatial Concept]
   770   C0333641:Atrophy [Pathologic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "sensory neuropathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0151313:Sensory neuropathy [Disease or Syndrome]
   861   C0442874:Neuropathy [Disease or Syndrome]
   861   C0445254:Sensory [Qualitative Concept]

Phrase: ":"

Phrase: "autopsy case report of two brothers."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0007320:case report [Intellectual Product]
   790   C0085973:Case Report [Intellectual Product]
   783   C0801757:Autopsy report [Clinical Attribute]
   783   C1548372:Autopsy Report [Intellectual Product]
   753   C0004398:Autopsy [Diagnostic Procedure]
   753   C0684224:Report [Intellectual Product]
   753   C0700287:Report [Health Care Activity]
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
   753   C3273238:Report [Intellectual Product]
Processing 00000000.tx.178: J. 

Phrase: "J."
Processing 00000000.tx.179: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.180: Sci., 87, 141152.[ISI][Medline] Pan, H., Lin, H.M., Ku, W.Y., Li, T.C., Li, S.Y. and Hsiao, K.M. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "87,"

Phrase: "141152."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532717:ku [Quantitative Concept]
  1000   C1881335:kU [Quantitative Concept]

Phrase: "W.Y.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "T.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: "Y."

Phrase: "and"

Phrase: "Hsiao,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.181: (2001) Haplotype analysis of the myotonic dystrophy type 1 (DM1) locus in Taiwan: implications for low prevalence and founder mutations of Taiwanese myotonic dystrophy type 1. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Haplotype analysis of the myotonic dystrophy type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "(DM1"

Phrase: ")"

Phrase: "locus in Taiwan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1708726:Locus [Gene or Genome]

Phrase: ":"

Phrase: "implications for low prevalence"

Phrase: "and"

Phrase: "founder mutations of Taiwanese myotonic dystrophy type 1."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   754   C2985435:Founder Mutation [Cell or Molecular Dysfunction]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.182: Eur. 

Phrase: "Eur."
Processing 00000000.tx.183: J. 

Phrase: "J."
Processing 00000000.tx.184: Hum. 

Phrase: "Hum."
Processing 00000000.tx.185: Genet., 9, 638641.[ISI][Medline] Paulson, H.L., Das, S.S., Crino, P.B., Perez, M.K., Patel, S.C., Gotsdiner, D., Fischbeck, K.H. and Pittman, R.N. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "638641."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paulson,"

Phrase: "H.L., Das,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   827   C0057671:DAS [Organic Chemical,Pharmacologic Substance]
   734   C2346686:h l [Quantitative Concept]

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Crino,"

Phrase: "P.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539794:P-B [Gene or Genome]

Phrase: "Perez,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Patel,"

Phrase: "S.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Gotsdiner,"

Phrase: "D."

Phrase: ","

Phrase: "Fischbeck,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pittman,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.186: (1997) Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Machado-Joseph disease gene product"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]
   717   C0024408:Machado-Joseph Disease [Disease or Syndrome]

Phrase: "is"

Phrase: "a cytoplasmic protein widely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed in brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.187: Ann. 

Phrase: "Ann."
Processing 00000000.tx.188: Neurol., 41, 453462.[ISI][Medline] Rebbeck, T.R., Kantoff, P.W., Krithivas, K., Neuhausen, S., Blackwood, M.A., Godwin, A.K., Daly, M.B., Narod, S.A., Garber, J.E., Lynch, H.T. et al. 

Phrase: "Neurol.,"

Phrase: "41,"

Phrase: "453462."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rebbeck,"

Phrase: "T.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kantoff,"

Phrase: "P.W., Krithivas,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Neuhausen,"

Phrase: "S."

Phrase: ","

Phrase: "Blackwood,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Godwin,"

Phrase: "A.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Daly,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Narod,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Garber,"

Phrase: "J.E.,"

Phrase: "Lynch,"

Phrase: "H.T. et al."
Processing 00000000.tx.189: (1999) Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Modification of BRCA1-associated breast cancer risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "by the polymorphic androgen-receptor CAG repeat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205341:Repeat [Functional Concept]
   804   C1547730:Repeat [Temporal Concept]
   804   C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.190: Am. 

Phrase: "Am."
Processing 00000000.tx.191: J. 

Phrase: "J."
Processing 00000000.tx.192: Hum. 

Phrase: "Hum."
Processing 00000000.tx.193: Genet., 64, 13711377.[ISI][Medline] Sasaki, M., Dahiya, R., Fujimoto, S., Ishikawa, M. and Oshimura, M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "64,"

Phrase: "13711377."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sasaki,"

Phrase: "M."

Phrase: ","

Phrase: "Dahiya,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fujimoto,"

Phrase: "S."

Phrase: ","

Phrase: "Ishikawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Oshimura,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.194: (2000) The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The expansion of the CAG repeat"

Phrase: "in exon 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the human androgen receptor gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1367578:Androgen Receptor Gene [Gene or Genome]
   902   C0314604:Human gene [Gene or Genome]
   861   C1335671:Receptor Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C1447749:androgen receptor, human [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "associated with uterine endometrial carcinoma."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0476089:Endometrial Carcinoma [Neoplastic Process]
   797   C0848454:Uterine carcinoma [Neoplastic Process]
   760   C0007097:Carcinoma [Neoplastic Process]
   760   C0042149:Uterine [Body Part, Organ, or Organ Component]
   760   C0227843:Endometrial [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.195: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.196: Carcinogen., 27, 237244.[ISI][Medline] Strachan, T. and Read, A.P. 

Phrase: "Carcinogen.,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0007090:Carcinogen [Hazardous or Poisonous Substance]
   900 E C0858970:Carcinogenicity [Neoplastic Process]
   900 E C2699976:CARCINOGENICITY [Regulation or Law]

Phrase: "27,"

Phrase: "237244."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strachan,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Read, A.P."
Processing 00000000.tx.197: (eds) (1999) Human Molecular Genetics, 2nd edn. 

Phrase: "(eds) (1999"

Phrase: ")"

Phrase: "Human Molecular Genetics,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   901   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   827   C0017398:Genetics [Biomedical Occupation or Discipline]
   827   C0017399:genetics [Biologic Function]
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "2nd edn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419408:EDN [Gene or Genome]
Processing 00000000.tx.198: John Wiley & Sons (Asia), Singapore. 

Phrase: "John Wiley & Sons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037683:Son [Family Group]

Phrase: "(Asia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003980:Asia [Geographic Area]
   928 E C0078988:Asian [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "Singapore."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037173:Singapore [Geographic Area]
Processing 00000000.tx.199: Takano, H., Cancel, G., Ikeuchi, T., Lorenzetti, D., Mawad, R., Stevanin, G., Didierjean, O., Durr, A., Oyake, M., Shimohata, T. et al. 

Phrase: "Takano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cancel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205544:Cancel [Qualitative Concept]

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lorenzetti,"

Phrase: "D."

Phrase: ","

Phrase: "Mawad,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stevanin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Didierjean,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Oyake,"

Phrase: "M."

Phrase: ","

Phrase: "Shimohata,"

Phrase: "T. et al."
Processing 00000000.tx.200: (1998) Close association between prevalences of dominantly inherited spinocerebellar ataxia with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Close"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "association between prevalences of dominantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "spinocerebellar ataxia with CAG-repeat expansions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   753   C0004134:Ataxia [Sign or Symptom]

Phrase: "and"

Phrase: "frequencies of large normal CAG alleles"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   767   C0017270:Frequencies, Allele [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "in Japanese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556094:Japanese [Population Group]

Phrase: "and"

Phrase: "Caucasian populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.201: Am. 

Phrase: "Am."
Processing 00000000.tx.202: J. 

Phrase: "J."
Processing 00000000.tx.203: Hum. 

Phrase: "Hum."
Processing 00000000.tx.204: Genet., 63, 10601066.[ISI][Medline] Timchenko, L.T. and Caskey, C.T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "63,"

Phrase: "10601066."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Timchenko,"

Phrase: "L.T."

Phrase: "and"

Phrase: "Caskey,"

Phrase: "C.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.205: (1996) Trinucleotide repeat disorders in humans: discussions of mechanisms and medical issues. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Trinucleotide repeat disorders in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012634:Disorders [Disease or Syndrome]

Phrase: ":"

Phrase: "discussions of mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0557061:discussions [Therapeutic or Preventive Procedure]
   756 E C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "medical issues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033213:Issue [Finding]
   827   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.206: FASEB J., 10, 15891597.[Abstract/Free FullText] Tishkoff, S.A., Goldman, A., Calafell, F., Speed, W.C., Deinard, A.S., Bonne-Tamir, B., Kidd, J.R., Pakstis, A.J., Jenkins, T. and Kidd, K.K. 

Phrase: "FASEB J.,"

Phrase: "10,"

Phrase: "15891597."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tishkoff,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Goldman,"

Phrase: "A.,"

Phrase: "Calafell,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Speed,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678536:Speed [Quantitative Concept]

Phrase: "W.C., Deinard,"

Phrase: "A.S.,"

Phrase: "Bonne-Tamir,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kidd,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Pakstis,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Jenkins,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kidd,"

Phrase: "K.K."
Processing 00000000.tx.207: (1998) A global haplotype analysis of the myotonic dystrophy locus: implications for the evolution of modern humans and for the origin of myotonic dystrophy mutations. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A global haplotype analysis of the myotonic dystrophy locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "implications for the evolution of modern humans"

Phrase: "and for the origin of myotonic dystrophy mutations."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0027126:Myotonic Dystrophy [Disease or Syndrome]
   770   C0410226:Myotonic Dystrophy [Disease or Syndrome]
   744   C0026882:Mutations [Genetic Function]
           genetic mutations
   744   C0079946:origin [Classification]
   744   C0333606:Dystrophy [Pathologic Function]
   744   C0439659:Origin [Temporal Concept]
   744   C1515981:And [Idea or Concept]
   744   C1550512:origin [Intellectual Product]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.208: Am. 

Phrase: "Am."
Processing 00000000.tx.209: J. 

Phrase: "J."
Processing 00000000.tx.210: Hum. 

Phrase: "Hum."
Processing 00000000.tx.211: Genet., 62, 13891402.[ISI][Medline] Wang, G., Ide, K., Nukina, N., Goto, J., Ichikawa, Y., Uchida, K., Sakamoto, T. and Kanazawa, I. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "62,"

Phrase: "13891402."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wang,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Goto,"

Phrase: "J.,"

Phrase: "Ichikawa,"

Phrase: "Y.,"

Phrase: "Uchida,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakamoto,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.212: (1997) Machado-Joseph disease gene product identified in lymphocytes and brain. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Machado-Joseph disease gene product"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]
   717   C0024408:Machado-Joseph Disease [Disease or Syndrome]

Phrase: "identified in lymphocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024264:Lymphocytes [Cell]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.213: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.214: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.215: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.216: Commun., 233, 476479.[ISI][Medline] Waring, J.D. and Korneluk, R.G. 

Phrase: "Commun.,"

Phrase: "233,"

Phrase: "476479."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Waring,"

Phrase: "J.D."

Phrase: "and"

Phrase: "Korneluk,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.217: (1998) Myotonic dystrophy. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Myotonic dystrophy."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0027126:Myotonic Dystrophy [Disease or Syndrome]
  1000   C0410226:Myotonic Dystrophy [Disease or Syndrome]
   861   C0333606:Dystrophy [Pathologic Function]
   789 E C0333607:Dystrophic [Functional Concept]
Processing 00000000.tx.218: In Oostra, B.A. 

Phrase: "In Oostra,"

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.219: (ed.), Trinucleotide Diseases and Instability. 

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Trinucleotide Diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Instability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444783:Instability [Finding]
Processing 00000000.tx.220: Springer-Verlag, Heidelberg. 

Phrase: "Springer-Verlag,"

Phrase: "Heidelberg."
Processing 00000000.tx.221: Yoshida, K.I., Yano, M., Chiba, K., Honda, M. and Kitahara, S. 

Phrase: "Yoshida,"

Phrase: "K.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yano,"

Phrase: "M."

Phrase: ","

Phrase: "Chiba,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Honda,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Kitahara,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.222: (1999) CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia. 

Phrase: "(1999"

Phrase: ")"

Phrase: "CAG repeat length in the androgen receptor gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1444754:Length [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]

Phrase: "is"

Phrase: "enhanced in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C2349975:Enhanced [Activity]

Phrase: "with idiopathic azoospermia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004509:AZOSPERMIA [Disease or Syndrome]
   861   C1321542:Azoospermia [Pathologic Function]
Processing 00000000.tx.223: Urology, 54, 10781081.[ISI][Medline] Young, I.E., Kurian, K.M., Mackenzie. 

Phrase: "Urology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042077:Urology [Biomedical Occupation or Discipline]
  1000   C1555893:Urology [Professional or Occupational Group]
  1000   C1556013:Urology [Professional or Occupational Group]

Phrase: "54,"

Phrase: "10781081."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Young, I.E., Kurian,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mackenzie."
Processing 00000000.tx.224: M.A., Kunkler, I.H., Cohen, B.B., Hooper, M.L., Wyllie, A.H. and Steel, C.M. 

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kunkler,"

Phrase: "I.H.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0021966:I- [Inorganic Chemical]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Cohen,"

Phrase: "B.B.,"

Phrase: "Hooper,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wyllie,"

Phrase: "A.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Steel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038239:Steel [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.225: (2000) The CAG repeat within the androgen receptor gene in male breast cancer patients. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The CAG repeat within the androgen receptor gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205341:Repeat [Functional Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]

Phrase: "in male breast cancer patients."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0150904:male patients [Organism Attribute]
   844   C1516213:Cancer Patient [Patient or Disabled Group]
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0238033:Male Breast Cancer [Neoplastic Process]
   756   C0242787:male breast cancer [Neoplastic Process]
Processing 00000000.tx.226: J. 

Phrase: "J."
Processing 00000000.tx.227: Med. 

Phrase: "Med."
Processing 00000000.tx.228: Genet., 37, 139140.[Free FullText] Yu, H., Bharaj, B., Vassilikos, E.J., Giai, M. and Diamandis, E.P. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "37,"

Phrase: "139140."

Phrase: "[Free FullText"

Phrase: "] Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bharaj,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Vassilikos,"

Phrase: "E.J.,"

Phrase: "Giai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Diamandis,"

Phrase: "E.P."
Processing 00000000.tx.229: (2000) Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Shorter CAG repeat length in the androgen receptor gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1444754:Length [Quantitative Concept]
   742   C1706316:LENGTH [Research Activity]

Phrase: "is"

Phrase: "associated with more aggressive forms of breast cancer."
Meta Candidates (Total=23; Excluded=5; Pruned=0; Remaining=18)
   793   C0006142:Cancer of Breast [Neoplastic Process]
           Breast Cancer
   793   C0678222:Cancer of Breast [Neoplastic Process]
           Breast Cancer
   789   C1286083:Form of breast [Clinical Attribute]
           breast forms
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C2945759:aggressive cancer [Neoplastic Process]
   761 E C0426786:Form of chest [Finding]
   744   C0001807:aggressive [Mental or Behavioral Dysfunction]
   744   C0006141:Breast [Body Part, Organ, or Organ Component]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0580822:Aggressive [Temporal Concept]
   744   C0998265:Cancer [Eukaryote]
   744   C1268990:Breast [Body Part, Organ, or Organ Component]
   744   C1306459:Cancer [Finding]
   720 E C0153661:thoracic cancer [Neoplastic Process]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1522492:Form [Functional Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.230: Breast Cancer Res. 

Phrase: "Breast Cancer Res."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2347379:RES [Finding]
   734   C0006142:Breast Cancer [Neoplastic Process]
   734   C0678222:Breast Cancer [Neoplastic Process]
Processing 00000000.tx.231: Treat., 59, 153161.[ISI][Medline] Zhang, S., Wu, H., Pan, A., Xiao, C., Zhang, G., Hou, Y. and Chu, J. 

Phrase: "Treat.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "59,"

Phrase: "153161."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang,"

Phrase: "S."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "A.,"

Phrase: "Xiao,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hou,"

Phrase: "Y."

Phrase: "and"

Phrase: "Chu,"

Phrase: "J."
Processing 00000000.tx.232: (2000) Low incidence of myotonic dystrophy in Chinese Hans is associated with a lower number of CTG trinucleotide repeats. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Low incidence of myotonic dystrophy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "in Chinese Hans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551910:Han [Language]

Phrase: "is"

Phrase: "associated with a lower number of CTG trinucleotide repeats."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   764   C0282537:Trinucleotide Repeats [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0179630:CTG [Medical Device]
   742   C0205341:repeats [Functional Concept]
   742   C0237753:*Number [Quantitative Concept]
   742   C0441994:Lower [Spatial Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1548802:Lower [Body Location or Region]
   742   C1705914:Repeats [Conceptual Entity]
   742   C1705968:CTG [Quantitative Concept]
   742   C2003888:Lower [Activity]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1547730:Repeat [Temporal Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.233: Am. 

Phrase: "Am."
Processing 00000000.tx.234: J. 

Phrase: "J."
Processing 00000000.tx.235: Med. 

Phrase: "Med."
Processing 00000000.tx.236: Genet., 96, 425428.[ISI][Medline] Submitted on March 23, 2001; 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "96,"

Phrase: "425428."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Submitted on March 23,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450348:23 [Quantitative Concept]
   770   C1515023:Submitted [Functional Concept]

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.237: resubmitted on January 28, 2001; 

Phrase: "resubmitted on January 28,"

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.238: accepted on February 21, 2002.

Phrase: "accepted on February 21,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1272684:Accepted [Qualitative Concept]
   770   C1548435:Accepted [Idea or Concept]
   737 E C1548601:Accept [Idea or Concept]

Phrase: "2002."

